rfhg_199758.1

Basic information about the TSS

---

TSS ID: rfhg_199758.1 TSS ID(Version3): hg_168609.1 hg_168608.1 Species: human Chr: chr17		Start: 80147119 End: 80147193 Strand: -
Source datasets	FANTOM5|PRJNA548673|PRJNA4843412|DRA013844|PRJNA401781 |PRJNA615891
Protocol	CAGE|ReCappable-seq|NETCAGE|SLIC_CAGE|TIF-seq2
TSS cluster detected*	8

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2969167,EH38E1890808)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000649764.2:0 ENST00000647795.1:0 ENST00000576547.2:0 ENST00000575957.1:0 D21853:0 AK290608:0 GeneID: 9775 HGNC/MGI_ID: HGNC:18683 UniProt_ID: A0A024R8W0 I3L3H2 Nearer transcript ids and distances: BC011151:2 BC004386:5 BC003662:26 X79538:67 AB383751:153 KJ892846:156 KJ906007:156 CU678566:156 CR456750:158 view more...

Gene_name: eukaryotic translation initiation factor 4A3 Gene_symbol: EIF4A3 Gene_synonyms: EIF4AIII Fal1 KIAA0111 Gene_source: HGNC:18683

TATA-Box annotation

---

Distance to TSS:	-28
Nearest PromoterID:	NM_014740
Entrez ID:	9775
Nearest Unigene:	Hs.389649
Nearest Refseq:	NM_014740
Nearest Ensembl:	ENSG00000141543
Gene Name:	eukaryotic translation initiation factor 4A3
Gene Alias:	DDX48|Fal1|MUK34|NMP265|NUK34|RCPS|eIF-4A-III|eIF4A-III|eIF4AIII
Gene Type:	protein-coding
CpG%:	0.148649
GC%:	0.600000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@EIF4A3 p2@EIF4A3 p3@EIF4A3 p4@EIF4A3 p5@EIF4A3
Sample		p1@EIF4A3	p2@EIF4A3	p3@EIF4A3	p4@EIF4A3	p5@EIF4A3
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	39.74	28.44	9.16	2.53	2.73
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	38.85	34.80	6.88	4.86	1.62
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	42.44	30.09	9.84	4.63	1.16
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	25.37	30.15	5.41	5.41	2.29
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	31.95	37.57	6.30	3.60	4.05
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	33.72	31.59	11.43	5.62	4.07
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	33.55	36.17	26.58	8.06	3.92
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	28.82	18.41	4.60	3.63	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	30.35	20.09	5.56	4.27	1.07
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	17.97	12.75	7.54	4.06	1.16
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	21.42	17.38	2.43	1.62	2.02
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	25.21	15.04	5.29	2.44	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	15.15	4.03	3.39	0.81	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	11.88	4.36	5.41	1.50	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	14.71	5.93	4.17	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	12.83	5.53	5.53	0.50	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	13.76	4.15	3.06	1.09	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	16.87	2.53	2.11	1.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	16.53	4.80	4.27	0.53	1.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	15.65	6.02	3.91	1.05	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	14.43	5.61	6.15	0.94	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	16.92	6.21	5.70	1.21	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	13.18	7.63	5.30	0.90	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	15.29	6.07	5.10	0.97	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	12.64	8.26	5.68	1.29	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	17.09	7.60	4.11	0.63	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	12.64	5.49	3.30	1.65	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	12.49	8.49	4.95	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	11.31	6.30	5.81	0.81	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	11.76	9.41	5.07	1.45	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	13.61	6.07	4.81	0.42	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	13.87	6.64	5.28	1.37	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	13.08	9.07	6.75	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	16.16	10.06	7.42	1.81	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	14.21	7.29	4.49	1.50	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	13.22	6.13	3.26	2.11	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	8.38	7.97	4.91	1.02	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	9.87	5.24	7.25	0.81	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	15.94	8.91	6.48	1.08	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	10.08	11.28	6.00	0.72	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	11.53	7.29	3.76	0.94	1.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	10.25	9.08	7.17	1.17	0.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	7.80	8.01	7.17	2.11	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	10.31	8.92	5.24	2.45	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	11.04	11.04	6.63	0.60	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	9.07	10.24	7.91	0.93	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	8.40	9.12	7.44	0.96	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	15.80	10.43	7.45	2.38	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	8.14	11.73	8.14	1.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	8.29	7.68	8.09	1.82	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	8.40	9.02	5.74	1.43	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	10.45	9.34	7.34	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	13.99	55.97	13.99	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	9.58	8.87	3.19	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	8.95	8.28	2.32	0.66	1.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	10.91	9.23	4.19	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	14.70	11.94	10.10	2.30	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	7.13	3.89	5.51	0.32	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	7.07	5.46	4.82	0.64	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	11.32	12.57	8.49	3.14	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	5.64	2.82	1.41	2.12	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	5.05	6.17	2.80	0.00	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	9.55	6.37	6.37	1.59	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	8.15	6.46	5.44	1.36	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	5.85	3.90	0.97	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	6.39	8.52	2.48	0.35	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	16.16	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	7.90	7.90	15.79	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	13.65	2.93	1.46	0.49	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	21.32	2.48	2.48	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	15.95	2.35	1.41	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	19.54	3.31	2.65	0.00	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	15.16	3.09	3.40	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	17.43	1.83	2.14	0.31	0.31
Adipocyte - breast, donor1	11376-118A8	16.31	5.39	6.02	1.27	0.48
Adipocyte - breast, donor2	11327-117E4	13.64	6.74	5.29	0.32	0.64
Adipocyte - omental, donor1	11473-119C6	17.30	5.60	3.94	1.15	1.02
Adipocyte - omental, donor2	11474-119C7	17.19	10.46	2.24	1.49	0.00
Adipocyte - omental, donor3	11475-119C8	15.74	5.02	1.34	0.00	0.33
Adipocyte - perirenal, donor1	11476-119C9	17.23	7.02	1.28	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	2.20	2.20	2.20	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	15.81	8.58	3.61	0.00	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	8.17	5.39	4.87	1.74	1.22
Adipocyte differentiation, day04, donor1	13019-139D4	15.65	8.80	6.06	0.78	0.78
Adipocyte differentiation, day04, donor2	13022-139D7	15.96	10.04	5.92	1.29	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	17.56	8.36	7.53	1.39	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	17.63	14.11	8.82	0.59	1.18
Adipocyte differentiation, day08, donor1	13020-139D5	8.04	5.79	5.95	1.13	0.40
Adipocyte differentiation, day08, donor2	13023-139D8	10.33	9.04	4.20	0.65	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	11.20	5.33	2.67	1.60	1.07
Adipocyte differentiation, day08, donor4	13029-139E5	6.68	9.46	3.90	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	11.23	4.99	4.16	0.42	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	11.55	5.53	3.01	0.50	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	10.47	7.20	1.64	0.33	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	7.92	4.57	1.52	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	11.93	13.70	5.30	1.55	0.44
Alveolar Epithelial Cells, donor2	11590-120G6	3.94	6.45	1.08	1.08	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	5.99	3.59	1.20	1.20	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	13.85	7.20	3.60	0.90	0.72
Amniotic Epithelial Cells, donor2	11613-122A2	15.06	5.02	1.67	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	6.78	10.89	4.93	0.82	0.62
Anulus Pulposus Cell, donor1	11248-116E6	18.08	9.27	6.06	2.06	0.69
Anulus Pulposus Cell, donor2	11463-119B5	13.96	10.04	4.41	0.73	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	9.44	5.84	0.45	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	15.63	6.95	1.30	0.00	0.87
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	4.28	4.28	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	12.85	4.78	2.39	0.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	1.26	3.79	1.26	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	11.22	7.26	5.28	0.66	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	10.72	2.27	1.62	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	16.50	4.37	1.46	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	8.31	4.75	4.16	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	12.05	4.90	0.75	0.38	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	9.43	4.35	2.90	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	7.52	8.78	5.02	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	10.38	4.45	2.80	0.82	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	9.55	4.09	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	9.50	4.37	1.36	0.45	0.30
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	6.43	4.82	1.61	0.54	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	12.28	4.72	3.21	1.13	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	12.83	2.94	3.21	0.53	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	10.73	1.95	0.98	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	10.28	5.14	3.48	0.17	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	14.41	7.20	2.40	3.60	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	3.54	3.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	8.23	4.29	2.06	0.34	0.34
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	12.58	0.00	8.39	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	11.16	7.28	0.49	0.97	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	9.87	5.31	2.66	0.38	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	9.69	8.48	4.85	1.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	11.40	7.41	1.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	11.12	5.34	2.14	1.07	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	9.81	4.39	3.61	1.03	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	9.85	3.75	0.47	0.00	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	6.43	4.50	2.25	0.96	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	9.99	2.85	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	10.53	2.34	0.58	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	10.54	3.61	0.60	0.00	0.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	4.75	3.56	5.94	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	15.77	7.12	2.54	0.00	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	9.42	6.11	1.78	1.02	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	12.07	4.45	1.27	0.00	1.27
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	7.34	6.47	1.73	0.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	7.41	3.60	2.54	0.21	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	9.28	3.77	4.35	0.58	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	5.67	5.67	0.00	0.00	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	8.65	4.24	2.54	0.68	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	9.27	2.32	4.63	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	12.68	10.56	2.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	9.01	2.14	1.72	0.43	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	15.04	9.02	3.01	1.20	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	10.21	7.29	0.73	0.73	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	9.88	4.83	3.68	0.46	0.92
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	12.75	2.55	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	9.15	6.61	2.29	0.51	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	10.12	5.99	2.68	0.21	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	8.57	3.67	4.90	0.92	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	10.52	6.21	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	7.10	4.66	3.10	1.11	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	4.58	1.53	7.63	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	14.95	3.32	1.11	0.00	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	8.74	3.71	1.59	0.26	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	10.54	4.36	2.91	0.36	1.09
Astrocyte - cerebellum, donor1	11500-119F6	20.02	10.19	3.81	0.74	0.12
Astrocyte - cerebellum, donor2	11580-120F5	14.89	6.85	1.88	0.00	0.17
Astrocyte - cerebellum, donor3	11661-122F5	6.71	5.45	5.45	1.26	0.42
Astrocyte - cerebral cortex, donor1	11235-116D2	19.52	13.59	6.62	1.39	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	27.18	14.88	10.52	1.94	1.62
Astrocyte - cerebral cortex, donor3	11392-118C6	36.54	10.59	8.95	2.09	1.94
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	35.21	18.12	15.25	4.59	2.18
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	32.70	22.43	19.79	4.51	2.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	30.95	15.93	15.93	3.64	1.59
Basophils, donor1	12241-129G9	29.03	21.18	15.17	1.83	1.57
Basophils, donor2	12242-129H1	25.26	26.70	18.76	4.33	2.89
Basophils, donor3	12243-129H2	12.79	10.58	10.44	2.79	1.18
Bronchial Epithelial Cell, donor1	11511-119G8	11.00	3.88	2.80	0.43	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	7.31	3.66	0.46	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	50.21	14.35	7.17	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	13.18	3.14	1.88	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	13.31	11.23	4.16	1.04	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	12.90	6.68	2.07	0.69	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	22.31	5.40	4.68	0.90	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	11.23	27.93	21.74	3.30	1.65
Burkitt's lymphoma cell line:RAJI	10476-106I8	20.73	23.29	16.54	2.10	2.56
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	64.91	16.31	9.59	2.24	1.60
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	10.34	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	11.27	12.40	13.53	2.25	0.56
CD14+ Monocytes, donor2	11305-117B9	18.93	11.88	7.61	1.11	0.93
CD14+ Monocytes, donor3	11381-118B4	6.59	11.85	10.98	1.76	2.85
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	16.42	11.89	11.32	1.42	0.57
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	5.69	13.65	8.72	4.55	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	15.78	4.93	6.25	1.97	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	9.97	17.06	13.15	3.04	0.87
CD14+ monocytes - mock treated, donor2	11873-125C1	12.97	22.33	10.26	2.11	0.91
CD14+ monocytes - mock treated, donor3	11883-125D2	15.40	29.37	13.50	3.08	1.42
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	9.04	19.42	13.22	3.01	1.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	9.11	33.67	14.90	3.04	1.10
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	9.67	41.90	21.32	4.21	2.73
CD14+ monocytes - treated with BCG, donor1	11860-125A6	11.16	43.86	31.92	6.85	4.50
CD14+ monocytes - treated with BCG, donor2	11870-125B7	10.86	41.13	25.10	5.52	1.07
CD14+ monocytes - treated with BCG, donor3	11880-125C8	13.93	68.99	38.74	4.13	4.35
CD14+ monocytes - treated with Candida, donor1	11868-125B5	17.09	55.49	38.87	6.09	2.81
CD14+ monocytes - treated with Candida, donor2	11878-125C6	13.20	65.48	32.74	3.70	2.11
CD14+ monocytes - treated with Candida, donor3	11888-125D7	15.53	77.66	41.05	16.64	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	9.82	15.47	13.68	3.72	1.34
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	5.99	25.54	13.57	1.80	0.40
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	9.79	41.02	23.53	3.54	1.67
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	9.15	48.50	27.68	7.78	3.43
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	9.50	34.38	25.56	2.71	2.04
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	10.91	64.60	35.35	3.93	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	15.33	30.40	20.44	3.50	2.15
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	12.91	35.76	20.94	4.36	2.44
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	14.31	42.08	24.41	5.47	2.95
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	7.16	20.21	9.19	2.76	1.10
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	10.22	34.17	15.85	2.47	1.76
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	10.53	44.75	26.32	3.51	2.63
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	13.08	48.48	30.17	8.72	5.06
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	9.29	45.34	30.11	5.58	2.97
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	15.74	76.52	46.99	6.04	4.53
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	6.96	22.11	20.88	2.05	1.64
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	10.20	35.47	17.62	1.39	0.93
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	12.06	52.20	30.85	5.57	2.55
CD14+CD16+ Monocytes, donor1	11789-124B7	27.25	11.55	5.89	0.22	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	27.49	6.01	6.47	1.15	0.46
CD14+CD16+ Monocytes, donor3	11912-125G4	47.01	8.23	4.77	0.43	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	30.21	9.81	10.90	2.65	0.62
CD14+CD16- Monocytes, donor2	11799-124C8	29.17	6.29	3.84	0.87	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	47.05	7.36	4.46	0.22	0.67
CD14-CD16+ Monocytes, donor1	11790-124B8	23.99	11.23	9.44	2.04	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	25.91	6.37	4.61	0.22	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	40.00	6.53	2.74	1.05	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	24.39	12.19	20.32	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	44.07	12.88	12.88	2.03	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	32.10	7.25	12.43	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	7.46	17.06	17.59	0.53	2.67
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	7.50	15.55	14.47	2.68	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	35.10	7.72	9.13	1.40	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	40.00	11.77	8.63	1.57	1.57
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	42.19	9.23	5.27	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	17.26	22.19	5.75	2.47	3.29
CD19+ B Cells, donor2	11624-122B4	3.63	18.86	7.98	2.18	0.00
CD19+ B Cells, donor3	11705-123B4	22.72	17.67	6.56	2.52	2.02
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	40.00	33.94	19.80	2.02	2.83
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	36.75	27.17	15.58	2.80	2.40
CD34+ Progenitors, donor1	11545-120B6	15.06	7.03	8.03	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	25.84	27.53	7.87	2.25	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	48.85	12.40	11.65	2.25	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	47.13	21.20	13.08	1.13	1.58
CD4+ T Cells, donor1	11225-116C1	10.35	34.28	27.85	5.00	1.43
CD4+ T Cells, donor2	11306-117C1	23.88	39.80	33.07	7.96	3.67
CD4+ T Cells, donor3	11382-118B5	25.62	35.99	29.28	7.32	3.66
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	15.57	13.27	8.68	1.02	1.02
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	19.09	13.48	9.21	3.14	1.35
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	32.48	6.32	3.74	0.86	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	22.28	17.07	18.96	5.69	0.95
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	25.99	9.83	10.53	0.70	2.11
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	52.74	13.18	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	11.42	14.02	8.09	1.16	0.43
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	8.30	27.45	16.27	6.10	2.03
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	19.02	16.77	13.38	2.26	1.29
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	22.41	17.93	8.97	3.59	2.24
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	18.17	10.83	4.89	0.70	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	32.12	11.00	7.48	0.00	1.32
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	23.19	18.13	4.64	3.79	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	16.21	18.49	16.41	2.70	0.83
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	36.09	9.02	15.37	3.01	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	22.84	13.87	8.43	1.90	1.09
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	30.55	8.04	1.61	0.54	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	37.66	8.97	1.79	1.79	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	19.28	24.11	12.98	2.97	1.48
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	12.56	14.95	11.70	1.95	1.73
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	22.49	13.03	6.51	1.26	1.26
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	17.70	28.31	11.63	4.04	4.55
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	20.36	15.60	5.20	3.90	0.87
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	37.04	13.51	5.23	1.31	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	67.30	9.40	6.43	0.00	1.48
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	66.47	9.23	6.46	0.00	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	85.15	6.98	5.58	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	10.25	18.00	7.75	0.83	1.11
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	11.53	14.72	5.89	0.49	0.49
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	61.60	18.48	6.16	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	56.22	10.39	8.24	1.07	1.43
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	59.55	5.54	8.31	2.77	1.38
CD8+ T Cells, donor1	11226-116C2	15.71	35.36	26.52	2.62	4.58
CD8+ T Cells, donor2	11307-117C2	14.64	39.42	28.53	6.01	4.88
CD8+ T Cells, donor3	11383-118B6	8.58	35.35	28.28	8.84	2.78
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	27.76	7.34	1.61	2.52	0.69
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	24.68	7.67	2.16	1.44	0.72
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	25.17	11.76	6.29	3.01	1.09
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	26.72	6.30	1.50	1.50	0.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	19.20	7.68	3.36	0.96	0.72
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	25.01	11.60	2.73	1.14	0.45
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	23.68	9.13	2.17	1.52	1.30
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	26.32	7.90	3.42	1.05	0.79
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	20.64	6.57	3.05	2.35	0.47
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	35.62	9.06	1.51	0.91	1.51
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	30.21	9.88	4.07	1.45	2.32
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	27.71	11.72	3.20	1.07	0.80
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	15.32	29.33	3.94	5.25	1.31
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	9.11	33.25	6.38	5.47	2.73
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	11.19	27.60	7.46	5.22	2.24
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	27.01	11.52	4.32	1.08	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	26.76	10.36	4.03	1.44	1.15
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	25.22	9.90	7.31	1.89	1.18
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	26.94	12.04	1.90	0.63	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	20.91	7.07	2.15	1.23	0.62
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	30.78	6.73	0.32	0.96	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	26.77	8.80	0.76	1.53	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	28.77	7.88	1.58	1.18	1.18
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	28.74	3.78	3.78	1.51	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	23.29	37.74	9.64	9.64	4.01
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	18.19	37.77	17.49	7.69	9.09
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	20.04	37.06	8.01	7.01	2.00
Cardiac Myocyte, donor1	11525-119I4	67.63	31.07	14.62	7.31	7.31
Cardiac Myocyte, donor2	11605-120I3	11.86	2.47	1.48	0.99	0.99
Cardiac Myocyte, donor3	11686-122I3	20.94	9.05	4.95	0.63	0.53
Chondrocyte - de diff, donor1	11261-116G1	6.93	5.20	3.12	0.69	0.00
Chondrocyte - de diff, donor2	11338-117F6	6.75	5.33	4.98	0.71	0.36
Chondrocyte - de diff, donor3	11410-118E6	7.85	9.44	6.94	1.93	0.80
Chondrocyte - re diff, donor2	11339-117F7	9.85	6.27	0.00	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	20.62	7.68	5.66	2.02	1.21
Ciliary Epithelial Cells, donor1	11242-116D9	19.97	9.52	8.49	1.61	0.92
Ciliary Epithelial Cells, donor2	11323-117D9	19.88	10.47	8.12	1.07	1.07
Ciliary Epithelial Cells, donor3	11399-118D4	23.98	8.32	6.99	1.33	1.15
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	32.65	7.15	7.98	1.28	0.92
Corneal Epithelial Cells, donor1	11526-119I5	6.81	3.29	2.42	0.44	0.00
Corneal Epithelial Cells, donor2	11606-120I4	14.79	10.24	6.83	2.28	0.00
Corneal Epithelial Cells, donor3	11687-122I4	17.89	5.37	4.35	0.77	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	5.61	18.16	14.36	2.48	0.99
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	6.31	20.82	15.14	3.78	1.26
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	6.90	17.25	3.45	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	19.76	11.01	10.91	1.73	1.19
Dendritic Cells - plasmacytoid, donor1	11228-116C4	30.75	69.69	61.50	14.01	5.47
Dendritic Cells - plasmacytoid, donor2	11309-117C4	21.54	106.42	88.14	11.75	9.79
Dendritic Cells - plasmacytoid, donor3	11385-118B8	41.62	123.41	38.72	9.19	4.36
Endothelial Cells - Aortic, donor0	11207-116A1	7.84	7.50	7.67	1.67	1.00
Endothelial Cells - Aortic, donor1	11263-116G3	10.56	7.63	3.52	0.59	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	14.42	8.20	4.52	1.41	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	16.91	5.50	9.83	1.57	0.79
Endothelial Cells - Artery, donor1	11264-116G4	12.80	5.24	2.62	0.58	0.87
Endothelial Cells - Artery, donor2	11341-117F9	16.00	13.18	8.00	0.71	0.94
Endothelial Cells - Artery, donor3	11413-118E9	16.30	12.27	10.17	2.80	1.05
Endothelial Cells - Lymphatic, donor1	11236-116D3	11.30	11.30	7.09	0.66	0.89
Endothelial Cells - Lymphatic, donor2	11317-117D3	11.56	6.09	3.65	0.91	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	9.87	5.07	2.26	0.00	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	12.78	5.05	1.78	0.00	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	12.50	5.73	4.17	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	6.38	6.38	4.82	1.42	0.57
Endothelial Cells - Thoracic, donor1	11266-116G6	16.81	11.60	3.60	1.60	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	15.20	3.14	2.10	0.52	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	28.33	17.52	10.44	2.24	1.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	20.86	12.17	9.56	3.04	1.30
Endothelial Cells - Umbilical vein, donor3	11400-118D5	27.48	16.49	11.36	3.05	1.59
Endothelial Cells - Vein, donor1	11267-116G7	15.93	12.51	1.14	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	24.45	6.99	2.10	0.70	1.40
Endothelial Cells - Vein, donor3	11416-118F3	17.43	12.25	8.01	2.20	1.10
Eosinophils, donor1	12244-129H3	30.49	45.74	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	39.61	64.36	79.21	13.20	9.90
Eosinophils, donor3	12246-129H5	42.80	78.47	67.77	10.70	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	8.55	3.18	1.22	0.00	0.73
Esophageal Epithelial Cells, donor2	11587-120G3	4.16	2.08	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	6.98	5.34	4.11	0.00	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	3.72	3.39	1.64	0.44	0.44
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	15.17	7.58	2.93	1.73	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	25.23	8.49	6.79	0.85	0.73
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	10.78	12.28	8.05	1.50	1.23
Fibroblast - Aortic Adventitial, donor2	11326-117E3	6.43	5.59	6.75	1.37	1.16
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	21.08	10.01	2.37	0.26	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	15.28	7.31	8.30	1.00	1.00
Fibroblast - Cardiac, donor1	11268-116G8	19.05	13.61	4.08	1.36	0.00
Fibroblast - Cardiac, donor2	11345-117G4	15.16	9.85	7.58	1.52	0.00
Fibroblast - Cardiac, donor3	11417-118F4	5.36	7.10	5.20	0.63	0.63
Fibroblast - Cardiac, donor4	11452-119A3	19.10	10.00	6.06	1.21	0.00
Fibroblast - Cardiac, donor5	11456-119A7	12.82	8.76	3.93	0.63	0.63
Fibroblast - Cardiac, donor6	11460-119B2	21.37	12.89	6.52	0.91	0.30
Fibroblast - Choroid Plexus, donor1	11492-119E7	8.98	8.31	2.68	0.40	0.27
Fibroblast - Choroid Plexus, donor2	11572-120E6	17.26	11.22	5.61	0.86	0.86
Fibroblast - Choroid Plexus, donor3	11653-122E6	38.08	4.39	5.86	1.46	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	24.68	6.46	2.77	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	9.33	8.99	10.52	0.85	0.68
Fibroblast - Dermal, donor1	11269-116G9	12.44	6.10	2.35	0.70	0.00
Fibroblast - Dermal, donor2	11346-117G5	25.00	9.91	6.60	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	22.85	4.96	5.56	1.21	0.85
Fibroblast - Dermal, donor4	11450-119A1	23.74	11.42	6.33	0.90	0.11
Fibroblast - Dermal, donor5	11454-119A5	30.35	11.69	6.98	1.74	0.17
Fibroblast - Dermal, donor6	11458-119A9	36.55	13.81	6.66	1.62	0.32
Fibroblast - Gingival, donor1	11237-116D4	16.45	7.91	5.41	1.25	0.83
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	22.01	10.48	12.31	1.57	0.52
Fibroblast - Gingival, donor2	11318-117D4	27.81	8.57	6.59	1.71	1.05
Fibroblast - Gingival, donor3	11394-118C8	15.47	8.80	7.44	1.74	0.77
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	17.66	9.35	5.19	1.04	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	5.46	7.22	8.28	0.88	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	18.40	15.90	14.97	2.49	1.09
Fibroblast - Gingival, donor6 (control)	11922-125H5	15.01	10.41	10.14	2.30	1.22
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	2.47	7.76	4.94	1.06	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	6.58	9.65	8.34	1.02	1.32
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	13.77	13.91	11.86	1.50	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	12.94	18.54	12.51	1.32	1.32
Fibroblast - Gingival, donor9 (control)	11927-125I1	9.98	8.07	5.87	1.17	0.73
Fibroblast - Lung, donor1	11270-116H1	24.47	9.52	2.72	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	37.30	1.49	1.49	0.00	1.49
Fibroblast - Lung, donor3	11419-118F6	30.18	10.13	7.60	2.11	1.69
Fibroblast - Lymphatic, donor1	11506-119G3	9.16	6.66	0.83	1.67	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	1.40	4.20	2.80	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	4.48	1.96	0.84	0.28	0.00
Fibroblast - Mammary, donor1	11540-120B1	13.40	5.68	3.65	1.62	1.62
Fibroblast - Mammary, donor2	11620-122A9	15.98	3.99	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	11.91	11.91	0.00	5.96	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	29.29	10.09	8.15	0.97	1.16
Fibroblast - Periodontal Ligament, donor2	11319-117D5	25.63	12.13	10.47	2.88	0.30
Fibroblast - Periodontal Ligament, donor3	11395-118C9	12.85	6.73	4.59	0.92	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	10.30	9.54	4.96	0.38	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	9.99	12.15	7.29	1.35	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	6.84	8.12	5.91	1.74	0.58
Fibroblast - Pulmonary Artery, donor1	11250-116E8	17.80	13.37	10.28	2.76	1.77
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	8.94	8.13	3.66	1.02	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	9.35	8.69	3.34	1.34	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	20.16	6.33	7.12	0.79	1.19
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	29.77	13.30	1.98	0.99	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	17.05	3.02	1.60	0.18	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	23.85	6.11	5.52	0.39	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	26.78	8.12	2.41	0.90	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	14.03	7.34	1.84	0.43	0.22
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	32.65	13.92	1.52	0.00	0.25
Fibroblast - skin normal, donor1	11553-120C5	16.41	4.10	2.13	0.33	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	22.46	8.22	9.42	1.00	0.60
Fibroblast - skin normal, donor2	11561-120D4	24.81	8.44	3.62	0.30	0.30
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	42.01	19.65	3.93	0.60	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	19.97	5.05	5.63	1.08	0.17
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	11.28	10.43	3.25	0.34	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	18.06	8.87	0.99	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	13.10	8.63	3.73	0.53	0.11
Fibroblast - skin walker warburg, donor1	11554-120C6	20.41	11.47	5.90	1.18	0.67
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	10.04	5.02	2.82	0.63	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	44.32	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	20.92	27.89	19.17	2.61	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	10.92	9.36	7.63	1.91	1.04
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	10.93	6.77	5.99	0.78	0.78
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	2.56	7.41	5.62	2.81	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	52.06	30.62	18.37	0.77	1.53
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	68.91	37.65	17.87	3.19	2.55
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	28.24	39.65	33.09	4.56	3.99
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	18.20	18.75	16.82	1.93	0.55
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	16.44	19.18	16.90	2.97	0.91
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	21.99	22.39	20.61	1.98	1.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	16.92	17.71	17.18	1.59	0.53
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	12.07	24.13	17.94	1.96	0.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	30.07	25.65	17.69	4.42	2.21
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	62.75	15.69	10.46	1.41	1.84
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	58.25	16.38	11.21	1.60	0.86
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	59.37	15.85	9.67	1.88	1.34
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	40.76	11.03	8.18	0.99	1.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	51.63	10.38	10.80	1.52	0.97
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	38.02	10.98	8.13	1.83	1.22
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	36.51	7.99	5.70	0.46	0.68
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	34.38	10.34	7.85	1.99	0.75
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	33.66	7.87	4.15	1.31	1.31
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	41.96	8.86	4.14	1.77	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	43.55	13.67	7.95	2.07	0.64
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	34.41	5.81	5.14	1.12	1.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	51.62	9.48	7.86	1.81	0.60
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	49.54	16.79	13.91	2.37	0.85
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	35.91	8.78	8.78	1.24	0.80
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	37.04	6.45	4.06	1.14	0.21
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	30.91	5.29	2.73	0.68	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	41.05	10.07	7.08	1.22	1.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	37.02	8.90	8.65	1.16	0.83
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	35.12	9.80	4.29	1.23	0.61
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	43.32	6.40	4.75	1.65	1.03
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	42.66	8.42	7.49	0.92	1.27
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	37.69	9.67	8.34	1.33	1.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	35.27	5.73	3.53	1.76	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	47.23	7.50	6.15	1.60	1.11
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	33.72	9.24	5.51	1.13	0.49
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	40.73	3.53	4.49	1.60	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	39.89	8.34	5.59	0.47	1.04
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	29.26	8.38	2.85	1.11	0.47
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	34.36	9.12	5.78	0.61	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	36.69	9.41	6.27	0.84	1.15
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	28.10	5.93	4.39	0.66	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	30.58	6.17	2.81	0.56	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	26.11	9.17	6.76	1.30	1.39
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	22.46	8.29	4.28	1.07	1.34
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	24.48	7.65	7.34	1.99	0.92
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	23.71	9.59	4.79	1.42	0.26
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	18.43	7.32	4.61	1.36	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	25.07	8.11	4.98	1.29	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	26.10	5.92	3.95	0.66	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	15.87	4.96	1.98	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	29.94	6.33	5.01	0.79	0.53
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	27.84	5.65	6.66	1.21	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	15.50	2.80	1.52	0.25	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	78.03	15.92	7.96	1.00	0.60
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	72.42	12.94	10.01	2.31	1.85
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	98.40	25.16	15.55	2.66	1.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	34.11	32.23	21.59	2.82	3.13
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	27.41	35.60	20.91	3.11	1.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	41.05	29.06	11.53	4.15	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	42.07	17.32	14.85	4.95	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	31.33	33.27	24.76	2.71	1.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	36.90	30.48	19.25	1.60	3.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	36.52	43.47	13.91	1.74	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	18.88	23.76	13.34	0.65	1.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	30.47	24.30	17.71	2.88	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	26.66	26.66	16.66	3.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	22.65	22.09	8.39	1.12	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	22.23	20.26	13.07	0.98	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	29.36	22.65	7.55	2.52	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	30.22	21.95	9.86	3.18	0.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	26.15	16.30	11.55	1.70	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	37.59	18.79	10.44	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	44.10	14.32	14.32	3.44	1.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	27.53	13.32	8.88	2.07	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	20.33	22.02	10.16	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	24.44	21.95	15.74	2.07	0.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	22.78	18.41	12.43	2.07	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	15.81	36.88	5.27	0.00	10.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	23.83	14.22	11.92	1.15	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	22.49	14.34	9.45	0.00	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	22.74	10.70	7.36	0.00	1.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	35.44	12.71	8.09	2.31	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	23.28	28.76	14.38	3.77	2.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	39.76	9.94	0.00	2.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	22.65	5.66	5.66	1.42	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	36.21	11.47	3.62	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	31.54	10.68	3.56	0.51	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	35.10	10.77	7.58	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	33.05	9.87	6.91	0.49	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	53.12	21.25	5.90	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	40.84	12.25	8.17	1.17	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	30.28	7.02	4.83	0.44	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	37.30	11.02	11.02	1.70	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	32.83	9.55	5.37	1.19	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	26.20	18.44	10.19	1.46	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	11.41	4.57	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	4.57	5.82	4.57	1.25	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	6.75	16.87	7.87	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	8.56	12.37	5.71	1.27	0.63
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	5.85	8.35	7.10	1.67	0.84
Hep-2 cells mock treated, biol_rep1	11898-125E8	21.58	37.60	21.12	5.69	3.25
Hep-2 cells mock treated, biol_rep2	11899-125E9	25.15	45.41	23.63	4.05	1.86
Hep-2 cells mock treated, biol_rep3	11900-125F1	21.61	38.22	19.57	2.73	2.28
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	23.06	42.63	24.70	6.67	3.72
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	24.93	46.64	24.93	4.51	1.72
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	21.74	36.17	18.08	5.60	1.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	21.05	35.62	21.54	5.73	2.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	18.53	33.62	18.53	3.09	1.54
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	26.59	37.48	13.46	2.56	1.60
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	10.63	4.48	1.12	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	5.19	3.03	1.30	0.00	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	26.44	15.86	10.58	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	10.58	6.00	3.53	0.00	0.71
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	13.08	3.63	0.73	0.00	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	22.20	14.51	8.92	2.10	0.35
Hepatocyte, donor1	11523-119I2	6.05	8.47	4.84	0.00	1.21
Hepatocyte, donor2	11603-120I1	10.77	7.54	3.23	0.00	0.00
Hepatocyte, donor3	11684-122I1	5.52	6.14	7.36	0.61	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	50.91	64.62	45.04	7.83	3.92
Intestinal epithelial cells (polarized), donor1	11246-116E4	11.01	23.07	21.50	3.50	2.45
Iris Pigment Epithelial Cells, donor1	11530-119I9	7.27	7.96	6.86	1.10	0.41
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	60.49	22.29	9.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	33.38	13.35	6.68	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	81.25	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	33.23	9.69	1.38	2.77	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	35.04	12.51	2.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	47.47	0.00	11.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	38.44	12.81	5.13	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	45.71	9.14	4.57	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	40.61	11.37	4.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	35.01	13.34	6.67	1.67	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	25.41	7.26	3.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	39.70	5.29	14.56	0.00	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	25.50	11.09	3.33	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	26.19	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	37.79	13.23	6.93	1.26	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	32.48	6.19	3.09	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	38.12	12.27	3.88	3.23	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	35.42	6.44	8.05	1.61	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	47.79	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	39.93	13.85	5.70	4.07	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	39.04	12.59	7.14	2.10	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	33.75	14.47	9.64	0.80	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	33.24	9.23	3.69	0.92	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	25.02	12.27	7.55	2.83	0.94
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	25.40	9.07	8.16	3.63	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	14.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	32.28	11.84	6.46	1.08	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	26.68	19.06	8.89	1.27	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	33.16	10.84	5.74	4.46	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	29.16	10.94	5.47	1.82	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	36.42	10.71	8.57	2.14	1.43
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	46.46	9.95	6.64	3.32	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	20.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	26.24	14.20	11.11	2.16	1.85
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	28.10	12.29	3.51	1.76	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	31.43	18.86	6.29	3.14	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	31.99	12.52	9.04	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	28.77	4.43	4.43	2.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	38.90	16.21	3.24	3.24	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	25.29	8.72	5.23	1.74	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	33.75	2.25	0.00	6.75	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	24.39	0.00	3.48	3.48	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	22.40	4.27	8.53	5.33	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	34.64	6.93	1.39	1.39	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	22.80	11.40	2.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	23.93	11.97	6.44	2.76	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	27.23	6.05	3.03	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	24.83	0.00	6.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	13.75	3.17	5.29	2.11	0.00
Keratinocyte - epidermal, donor1	11272-116H3	9.14	6.04	4.73	1.06	0.49
Keratinocyte - epidermal, donor2	11349-117G8	9.37	6.44	1.76	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	21.58	11.07	8.05	1.61	0.85
Keratinocyte - oral, donor1	11251-116E9	31.22	9.76	6.92	1.59	1.25
Keratocytes, donor1	11527-119I6	28.19	6.88	4.13	0.00	1.03
Keratocytes, donor2	11607-120I5	4.69	5.86	8.20	0.00	0.00
Keratocytes, donor3	11688-122I5	33.39	10.87	8.10	1.78	1.38
Krukenberg tumor cell line:HSKTC	10687-109F3	15.39	32.97	13.19	2.20	2.20
Lens Epithelial Cells, donor1	11529-119I8	15.10	7.55	5.39	1.08	1.08
Lens Epithelial Cells, donor2	11609-120I7	13.72	7.84	5.65	1.27	0.58
Lens Epithelial Cells, donor3	11690-122I7	17.36	8.78	7.37	1.31	0.50
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	16.13	5.22	5.57	0.95	0.95
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	17.30	5.86	6.42	0.84	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	12.44	8.97	5.35	2.36	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	16.13	6.99	3.76	1.08	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	17.02	11.03	8.19	1.26	1.26
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	9.81	8.52	5.82	1.40	0.75
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	17.24	10.67	2.46	1.23	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	16.43	7.84	7.84	0.76	1.01
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	13.09	7.88	5.35	1.69	0.70
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	16.22	6.72	7.12	1.58	1.58
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	14.35	7.56	6.20	1.36	1.16
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	13.89	7.78	4.81	1.11	0.93
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	20.56	6.97	4.53	0.70	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	15.98	8.11	5.25	2.15	0.72
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	13.32	8.38	6.04	0.55	0.96
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	21.87	7.39	6.16	1.85	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	9.66	9.98	7.17	1.25	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	12.08	8.23	5.86	1.46	1.10
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	17.44	8.89	4.61	0.99	0.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	16.11	8.49	4.10	1.76	1.17
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	17.43	6.97	3.49	1.24	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	12.61	5.82	3.39	1.45	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	17.23	8.62	7.00	1.35	0.81
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	12.56	10.75	5.90	1.36	0.45
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	17.11	7.78	4.15	1.04	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	16.96	8.38	6.70	0.63	0.84
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	13.98	7.52	4.51	2.86	0.60
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	20.64	11.01	4.82	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	13.17	9.97	9.41	3.01	0.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	12.83	9.97	5.94	1.59	1.06
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	18.90	10.66	7.27	1.45	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	12.57	8.93	9.26	1.98	1.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	14.50	7.43	6.44	1.61	1.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	18.88	7.77	5.18	1.11	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	16.31	7.41	6.67	1.48	0.99
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	11.69	8.94	4.95	1.51	1.65
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	18.66	8.68	7.40	1.61	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	16.43	10.65	5.48	2.13	0.91
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	16.94	9.94	5.74	1.96	0.56
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	18.13	12.44	5.69	1.78	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	11.15	12.12	5.82	1.45	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	12.29	8.09	4.51	1.09	0.62
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	21.13	12.89	7.16	1.79	1.07
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	15.35	9.80	6.21	2.94	0.98
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	15.07	7.06	7.53	1.65	0.94
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	15.72	10.27	7.55	1.86	1.49
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	13.32	9.22	7.94	1.28	0.51
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	12.83	6.86	3.28	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	13.60	22.66	20.39	4.53	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	10.74	16.11	10.74	2.30	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	17.81	22.27	11.13	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	14.81	24.54	19.46	3.81	2.12
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	8.44	18.29	8.44	0.70	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	13.08	21.48	7.47	0.93	1.87
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	15.46	23.19	15.97	3.09	1.55
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	22.60	16.65	3.57	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	12.67	22.62	18.32	3.39	1.36
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	21.52	23.85	15.41	4.65	1.16
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	14.86	18.91	14.41	3.60	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	16.39	23.44	22.36	3.12	1.63
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	19.00	20.54	19.00	3.08	1.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	18.00	14.47	14.11	2.12	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	17.99	22.65	4.66	1.33	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	14.26	20.38	17.83	1.02	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	15.21	20.01	11.74	2.13	2.13
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	19.65	23.05	15.68	2.27	1.89
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	13.50	28.22	16.57	3.68	2.45
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	13.86	30.99	7.34	2.45	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	18.33	25.82	17.08	3.96	2.08
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	14.57	24.94	17.10	1.96	1.12
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	10.30	29.88	12.36	2.06	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	16.84	21.77	20.61	2.61	1.16
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	16.14	20.03	15.84	2.09	1.20
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	13.28	26.00	9.96	2.21	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	18.38	25.45	16.26	2.47	1.77
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	19.91	23.97	18.44	1.84	1.11
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	20.72	19.57	14.97	1.15	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	17.65	26.86	11.51	2.30	1.54
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	14.15	18.68	20.38	2.26	1.70
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	8.20	19.69	9.85	0.82	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	11.75	14.01	15.82	3.62	1.36
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	10.05	18.67	18.67	7.18	2.87
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	15.68	17.18	12.70	2.24	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	14.86	24.53	24.15	2.23	1.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	14.65	26.28	23.26	3.88	1.29
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	11.13	21.41	15.41	2.57	2.57
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	15.66	23.32	17.33	2.00	2.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	18.10	16.89	15.08	2.41	1.21
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	17.06	18.49	13.51	2.84	1.42
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	16.15	24.75	15.81	3.44	2.41
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	12.35	22.54	16.10	4.29	1.61
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	16.16	26.93	10.77	2.69	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	16.67	21.11	18.89	2.22	1.11
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	19.77	31.40	25.58	2.33	2.33
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	12.69	22.21	9.52	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	14.41	23.21	18.01	2.40	1.20
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	18.17	26.17	16.72	3.63	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	13.03	22.23	16.86	0.77	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	14.31	25.16	18.25	4.44	1.48
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	17.88	23.52	25.41	4.70	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	19.61	24.14	18.60	2.01	1.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	12.62	18.48	15.77	4.96	2.25
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	20.65	22.37	15.49	1.72	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	13.81	26.72	13.36	2.23	1.34
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	15.25	26.20	17.60	3.52	1.17
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	17.15	25.07	19.79	6.60	1.98
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	20.24	25.43	15.57	2.08	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	15.75	20.13	22.75	3.50	1.75
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	10.62	27.96	19.01	4.47	1.68
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	21.20	28.27	16.78	2.21	2.21
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	18.90	20.83	20.06	2.31	1.54
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	18.74	26.33	26.84	8.10	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	10.09	26.43	13.94	2.88	0.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	19.48	21.07	19.88	1.99	1.19
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	20.05	21.27	13.37	1.82	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	8.99	19.37	3.46	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	14.82	23.94	19.00	1.90	1.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	14.98	30.99	20.14	1.03	2.58
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	10.28	15.72	2.42	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	20.92	20.60	19.33	4.12	0.63
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	13.86	22.39	17.59	5.86	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	14.94	22.41	5.17	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	16.97	24.17	14.91	3.60	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	22.64	28.29	23.34	4.24	2.12
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	18.73	25.54	3.40	0.57	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	15.39	27.04	21.63	2.08	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	28.97	30.54	17.23	5.48	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	15.87	32.57	5.43	0.84	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	13.47	28.81	22.30	1.39	3.72
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	18.06	32.78	21.41	2.68	2.01
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	14.97	25.66	3.74	0.53	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	21.42	35.56	25.46	4.45	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	31.20	33.04	20.19	4.59	1.84
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	15.11	32.90	5.33	0.89	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	17.67	31.34	13.11	3.99	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	17.64	31.44	19.17	2.30	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	14.23	18.06	6.57	0.55	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	12.47	29.84	20.94	4.01	3.56
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	16.38	24.44	28.08	3.90	2.86
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	17.24	24.53	3.98	0.00	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	14.55	14.55	27.02	0.00	2.08
Macrophage - monocyte derived, donor1	11232-116C8	26.21	7.98	4.33	1.37	0.23
Macrophage - monocyte derived, donor2	11313-117C8	3.85	11.74	8.07	1.10	0.55
Macrophage - monocyte derived, donor3	11389-118C3	12.45	7.34	4.06	2.88	0.66
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	7.43	21.24	11.68	1.06	0.00
Mallassez-derived cells, donor2	11929-125I3	4.60	6.34	2.22	0.63	0.48
Mallassez-derived cells, donor3	11930-125I4	13.20	8.62	4.45	0.69	0.14
Mammary Epithelial Cell, donor1	11273-116H4	19.43	9.17	10.36	2.09	0.70
Mammary Epithelial Cell, donor2	11350-117G9	17.37	9.56	4.92	1.74	1.16
Mammary Epithelial Cell, donor3	11422-118F9	11.72	10.73	7.23	1.75	0.00
Mast cell - stimulated, donor1	11487-119E2	27.80	21.69	16.95	4.07	1.36
Mast cell, donor1	11563-120D6	9.41	32.98	23.25	2.92	2.38
Mast cell, donor2	11565-120D8	36.26	36.55	27.93	4.75	3.57
Mast cell, donor3	11566-120D9	30.84	18.91	13.06	2.93	0.45
Mast cell, donor4	11567-120E1	36.52	33.33	28.01	7.27	3.55
Mast cell, expanded and stimulated, donor5	11940-126A5	10.20	28.28	16.19	2.99	1.44
Mast cell, expanded and stimulated, donor8	11942-126A7	11.67	17.51	21.60	1.75	1.17
Mast cell, expanded, donor5	11939-126A4	13.65	33.61	26.62	5.28	2.87
Mast cell, expanded, donor8	11941-126A6	4.18	36.49	27.28	5.19	4.35
Melanocyte - dark, donor1	11502-119F8	16.02	7.96	5.77	0.99	0.40
Melanocyte - dark, donor2	11582-120F7	14.54	6.58	3.81	0.69	0.00
Melanocyte - dark, donor3	11663-122F7	13.98	9.42	7.90	1.16	0.29
Melanocyte - light, donor1	11274-116H5	7.29	5.17	1.41	0.24	0.00
Melanocyte - light, donor2	11351-117H1	6.82	5.46	4.78	0.68	0.00
Melanocyte - light, donor3	11423-118G1	9.54	6.07	9.54	1.73	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	19.89	18.43	11.77	2.39	2.92
Melanocyte, donor2 (MC+2)	12739-135I3	11.30	14.52	13.72	2.69	1.61
Melanocyte, donor3 (MC+3)	12837-137B2	9.11	7.50	4.02	0.00	0.27
Meningeal Cells, donor1	11493-119E8	22.33	8.56	1.98	0.12	0.00
Meningeal Cells, donor2	11573-120E7	18.93	7.92	3.08	0.88	0.00
Meningeal Cells, donor3	11654-122E7	28.20	11.90	9.70	1.22	0.65
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	24.24	13.40	7.98	0.86	0.86
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	7.65	5.13	4.63	1.41	0.70
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	1.31	3.94	2.63	0.00	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	9.16	5.23	2.62	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	33.01	18.66	7.89	1.44	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	6.78	8.05	2.96	0.21	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	8.04	7.54	3.02	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	7.03	9.23	6.15	0.22	0.66
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	15.34	6.58	5.84	1.46	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	5.93	9.41	5.52	0.82	0.41
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	5.54	9.97	3.46	0.83	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	9.29	5.95	1.49	0.00	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	18.16	6.45	7.24	0.92	0.53
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	12.46	2.08	1.78	0.30	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	4.67	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	22.41	7.68	5.76	1.28	1.28
Mesenchymal stem cells - adipose, donor0	11217-116B2	40.05	13.11	12.41	1.77	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	17.51	9.69	6.88	0.94	0.63
Mesenchymal stem cells - umbilical, donor0	11214-116A8	48.62	17.42	9.43	2.18	0.00
Mesothelial Cells, donor1	11247-116E5	7.69	5.30	4.51	1.06	0.27
Mesothelial Cells, donor2	12156-128G5	8.01	4.50	3.50	0.00	0.50
Mesothelial Cells, donor3	11402-118D7	7.52	4.77	3.47	1.45	0.29
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	5.40	21.61	21.61	2.70	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	7.88	12.81	6.65	0.74	0.49
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	7.07	18.26	12.07	3.83	1.77
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	10.37	44.94	17.29	13.83	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	10.54	11.16	4.96	1.55	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	4.77	12.24	9.13	1.66	1.66
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	11.58	23.16	25.48	6.95	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	6.51	11.26	4.50	1.00	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	7.91	11.17	11.17	3.72	2.33
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	38.93	19.47	38.93	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	6.50	10.77	7.52	1.02	1.22
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	4.36	15.44	8.71	2.77	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	34.21	17.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	4.42	8.85	6.19	0.88	1.77
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	10.26	15.20	9.12	2.28	0.76
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	6.58	17.11	27.63	3.95	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	4.46	9.13	4.88	0.85	0.85
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	5.52	13.81	14.73	1.84	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	4.77	9.84	3.87	0.60	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	1.68	18.44	15.09	5.03	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	33.95	33.95
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	3.76	8.53	4.27	0.50	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	4.52	12.12	8.32	1.19	1.19
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	8.29	22.67	12.72	2.76	1.66
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	3.45	6.68	4.14	0.46	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	5.89	9.89	5.05	1.26	1.68
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	5.10	8.15	5.10	0.41	1.22
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	4.93	5.79	3.22	0.64	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	5.56	12.00	10.23	1.56	0.67
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	20.64	10.32	30.96	10.32	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	4.60	7.88	5.48	0.66	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	4.06	11.15	9.63	3.55	2.03
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	9.94	13.26	4.97	3.31	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	4.62	10.87	3.53	1.63	0.82
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	4.71	7.94	9.70	1.18	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	10.90	21.81	10.90	4.36	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	4.32	7.69	3.36	2.40	0.96
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	5.60	10.41	8.40	1.60	0.80
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	5.48	17.83	6.86	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	8.01	7.51	5.51	1.50	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	26.95	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	8.15	14.27	4.08	0.00	2.04
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	7.01	11.39	3.94	0.88	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	2.21	15.45	11.04	2.21	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	14.09	16.65	11.53	1.92	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	6.69	8.68	4.71	0.74	0.50
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	2.09	12.53	6.26	1.39	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	11.05	24.31	11.05	6.63	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	6.84	6.50	4.44	0.00	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	7.44	14.44	4.38	0.44	1.31
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	8.17	19.18	9.59	2.49	1.78
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	9.54	9.26	2.81	1.12	1.12
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	7.48	10.39	8.73	1.66	2.08
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	8.74	18.07	9.32	2.33	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	9.65	7.54	4.52	0.60	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	9.18	16.28	7.51	0.42	2.09
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	28.88	7.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	9.24	13.85	6.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	7.97	19.92	6.26	2.28	1.71
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	8.43	11.33	6.63	2.07	0.55
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	9.85	9.33	2.85	1.55	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	7.72	13.30	7.72	2.14	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	8.89	12.70	13.97	1.27	1.27
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	9.61	13.34	7.47	1.07	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	8.38	13.17	6.88	0.60	0.60
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	5.93	7.49	4.52	0.85	0.71
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	9.24	11.78	7.01	0.96	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	10.17	13.05	7.96	1.55	1.11
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	10.62	9.48	8.72	1.52	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	11.08	7.39	5.40	0.28	0.57
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	10.32	12.54	7.62	0.74	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	10.43	13.03	1.96	3.26	1.30
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	11.47	5.00	5.00	0.88	0.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	8.36	14.13	6.05	2.02	0.86
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	7.01	5.77	7.42	0.41	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	10.42	10.12	2.98	1.19	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	3.77	7.53	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	16.04	14.26	3.56	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	5.91	7.89	3.94	0.99	0.99
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	5.26	8.42	3.16	0.00	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	6.72	10.87	7.12	2.17	0.59
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	11.18	11.18	3.73	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	5.26	5.63	2.63	0.75	0.75
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	5.59	9.85	4.79	1.86	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	8.60	9.39	5.54	0.90	0.45
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	10.31	2.21	2.21	0.74	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	6.60	6.60	2.93	1.10	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	9.33	9.33	7.78	1.56	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	6.95	7.48	6.95	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	11.59	3.86	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	6.06	4.04	4.04	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	3.37	9.28	3.37	0.42	0.84
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	2.72	73.54	25.88	0.00	2.72
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	1.91	8.27	4.45	0.64	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.00	0.81	4.05	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	3.02	25.68	19.64	3.02	3.02
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	17.13	553.89	262.67	51.39	51.39
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	16.31	280.57	185.96	22.84	6.52
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	19.01	133.07	76.04	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	213.33	125.49	25.10	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	9.26	7.11	3.88	0.86	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	9.41	5.75	3.14	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	3.34	2.00	2.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	1.67	1.67	2.09	0.42	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	10.65	12.36	7.80	1.90	0.76
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	15.96	15.96	14.36	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	2.72	4.76	0.68	0.00	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	9.19	11.03	1.84	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	3.77	2.51	0.84	0.00	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	0.93	3.72	2.79	0.70	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	3.78	2.97	1.62	0.00	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	6.52	6.31	3.78	0.63	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	0.00	11.13	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	2.98	2.98	0.99	0.00	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	5.68	3.25	2.44	0.27	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	1.59	2.49	1.36	0.68	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	6.21	1.96	1.80	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	5.10	8.38	4.37	1.09	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	3.71	4.77	1.06	0.53	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	1.20	3.60	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	7.88	5.91	5.91	0.66	0.98
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	0.98	2.11	0.49	0.65	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	6.70	7.58	4.06	0.88	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	6.33	4.22	2.11	1.41	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	2.76	1.84	1.38	0.92	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	1.61	0.96	2.89	0.00	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	2.07	6.21	4.83	1.72	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	17.70	15.17	7.59	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	5.35	5.35	6.46	1.56	0.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	3.81	4.23	2.12	1.69	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	3.56	4.98	1.66	0.71	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	3.43	4.29	2.58	0.43	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	9.03	9.03	9.03	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	7.33	2.33	2.33	0.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	4.06	7.66	3.61	1.35	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	4.36	5.16	4.36	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	0.93	2.79	0.93	0.00	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	5.30	4.16	3.41	0.00	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	1.63	1.96	0.98	0.33	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	6.54	1.74	0.44	0.44	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	4.98	8.14	2.71	0.90	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	1.76	1.76	0.88	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	3.32	1.99	0.66	0.00	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	5.46	0.99	0.50	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	1.53	2.30	0.38	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	14.82	3.93	3.33	0.00	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	5.75	6.85	4.86	0.88	0.66
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	4.07	3.39	0.68	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	5.11	25.55	5.11	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	4.88	3.66	0.61	0.00	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	0.63	1.57	0.94	0.63	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	7.26	3.33	0.91	0.00	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	3.16	0.79	0.79	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	6.80	18.14	6.80	1.13	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	5.06	20.23	5.06	0.00	0.00
Myoblast, donor1	11241-116D8	5.22	11.06	9.32	1.37	0.99
Myoblast, donor2	11322-117D8	13.43	13.81	9.97	1.73	1.15
Myoblast, donor3	11398-118D3	9.08	8.41	6.73	2.19	0.50
NK T cell leukemia cell line:KHYG-1	10777-110G3	12.84	43.78	31.96	8.46	3.06
Natural Killer Cells, donor1	11230-116C6	16.61	19.37	18.45	2.46	0.92
Natural Killer Cells, donor2	11311-117C6	12.97	25.33	22.32	5.13	2.11
Natural Killer Cells, donor3	11387-118C1	10.49	28.90	21.53	3.31	2.21
Neural stem cells, donor1	11275-116H6	38.11	8.35	8.71	1.81	1.09
Neural stem cells, donor2	11352-117H2	9.63	7.70	5.78	0.00	0.00
Neurons, donor1	11494-119E9	55.76	23.90	12.52	5.69	0.00
Neurons, donor2	11574-120E8	51.74	10.57	8.37	1.98	1.32
Neurons, donor3	11655-122E8	27.95	11.51	9.04	2.47	0.00
Neutrophils, donor1	11233-116C9	16.70	15.78	10.21	0.93	0.00
Neutrophils, donor2	11314-117C9	14.49	14.49	11.60	0.00	0.00
Neutrophils, donor3	11390-118C4	13.44	11.61	12.22	1.83	3.05
Nucleus Pulposus Cell, donor1	11252-116F1	18.29	10.33	9.02	1.90	1.07
Nucleus Pulposus Cell, donor2	11409-118E5	20.84	5.21	3.58	1.63	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	13.64	6.62	2.61	0.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	6.19	3.17	3.17	0.83	0.28
Olfactory epithelial cells, donor2	11934-125I8	7.82	4.20	5.07	1.30	0.29
Olfactory epithelial cells, donor3	11935-125I9	3.18	5.79	2.61	0.45	0.68
Olfactory epithelial cells, donor4	11936-126A1	10.32	7.50	5.55	0.78	0.78
Oligodendrocyte - precursors, donor1	11496-119F2	15.65	6.62	3.61	1.20	0.00
Osteoblast - differentiated, donor1	11276-116H7	12.55	5.32	4.04	0.43	0.21
Osteoblast - differentiated, donor2	11353-117H3	5.72	12.57	3.43	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	4.97	3.10	1.86	1.24	0.62
Osteoblast, donor1	11277-116H8	19.74	7.62	7.23	1.37	1.17
Osteoblast, donor2	11354-117H4	17.56	9.13	3.51	1.40	2.81
Osteoblast, donor3	11426-118G4	21.86	9.06	7.46	1.96	0.89
Pancreatic stromal cells, donor1	11249-116E7	12.80	8.34	8.17	1.43	0.76
Pericytes, donor1	11491-119E6	8.01	2.67	1.67	0.00	0.22
Pericytes, donor2	11571-120E5	6.34	2.72	0.68	0.23	0.00
Pericytes, donor3	11652-122E5	12.21	5.70	4.68	0.61	0.41
Perineurial Cells, donor1	11499-119F5	11.42	6.78	5.43	0.79	0.68
Perineurial Cells, donor2	11579-120F4	9.39	4.14	2.30	1.01	0.18
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	15.94	7.01	9.88	1.27	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	23.02	10.53	8.08	2.45	0.73
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	19.80	5.95	5.05	1.94	0.65
Placental Epithelial Cells, donor1	11278-116H9	12.44	22.24	11.96	3.35	2.39
Placental Epithelial Cells, donor2	11355-117H5	13.31	12.20	1.11	1.11	2.22
Placental Epithelial Cells, donor3	11427-118G5	20.81	9.82	5.89	1.57	0.79
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	12.66	3.48	2.53	0.32	0.00
Preadipocyte - breast, donor1	11467-119B9	12.94	5.06	3.38	0.94	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	20.75	8.61	5.22	1.04	0.52
Preadipocyte - breast, donor2	11328-117E5	17.34	5.40	7.20	1.35	1.13
Preadipocyte - omental, donor1	11468-119C1	15.45	5.86	5.01	0.96	0.96
Preadipocyte - omental, donor2	11329-117E6	14.40	9.17	3.49	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	11.17	5.30	6.59	1.43	1.15
Preadipocyte - perirenal, donor1	11469-119C2	19.69	2.95	2.95	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	15.97	8.91	7.37	1.23	0.61
Preadipocyte - subcutaneous, donor2	11356-117H6	31.70	15.76	12.04	2.48	0.53
Preadipocyte - subcutaneous, donor3	11428-118G6	17.88	12.43	9.03	2.04	1.53
Preadipocyte - visceral, donor1	11280-116I2	25.43	6.99	5.68	1.02	0.65
Preadipocyte - visceral, donor2	11357-117H7	16.11	8.74	9.66	3.22	0.46
Preadipocyte - visceral, donor3	11429-118G7	19.02	9.30	5.22	0.63	0.21
Prostate Epithelial Cells (polarized), donor1	11253-116F2	5.58	24.59	21.12	3.92	2.72
Prostate Epithelial Cells, donor2	11331-117E8	6.23	8.94	7.58	2.17	1.35
Prostate Epithelial Cells, donor3	11404-118D9	5.14	4.35	3.06	0.98	0.43
Prostate Stromal Cells, donor1	11254-116F3	10.02	15.15	14.81	2.73	1.71
Prostate Stromal Cells, donor2	11332-117E9	10.22	12.73	14.88	5.02	1.08
Prostate Stromal Cells, donor3	11405-118E1	10.43	6.05	7.20	1.04	0.63
Renal Cortical Epithelial Cells, donor1	11516-119H4	17.88	4.38	2.55	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	24.95	6.03	6.86	0.90	0.07
Renal Epithelial Cells, donor1	11517-119H5	13.19	3.04	1.52	0.51	0.00
Renal Epithelial Cells, donor2	11597-120H4	19.21	7.11	2.85	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	23.82	6.56	7.52	0.95	0.64
Renal Glomerular Endothelial Cells, donor1	11514-119H2	10.89	4.77	2.72	0.00	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	15.36	10.24	3.37	1.08	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	39.07	15.54	7.55	0.89	0.89
Renal Glomerular Endothelial Cells, donor4	11783-124B1	2.66	0.67	2.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	17.17	6.16	2.86	0.44	0.22
Renal Mesangial Cells, donor2	11598-120H5	10.03	11.91	3.76	1.25	1.25
Renal Mesangial Cells, donor3	11679-122H5	8.88	4.72	2.77	0.28	0.55
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	28.18	6.44	3.76	0.54	0.54
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	13.07	5.06	3.37	0.42	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	12.92	7.91	4.63	0.77	0.77
Retinal Pigment Epithelial Cells, donor0	11215-116A9	21.52	8.56	5.44	2.07	0.78
Retinal Pigment Epithelial Cells, donor1	11528-119I7	15.35	2.84	0.85	0.00	0.57
Retinal Pigment Epithelial Cells, donor2	11608-120I6	10.29	2.06	3.09	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	12.04	5.02	8.28	1.25	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	13.23	14.97	13.36	1.74	1.20
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	33.95	25.91	9.83	3.57	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	18.71	27.52	10.46	1.10	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	29.58	38.28	13.34	5.80	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	36.02	45.64	13.26	3.12	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	31.68	39.13	29.59	4.97	3.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	37.25	36.14	38.37	4.35	2.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	35.97	43.17	26.30	6.08	2.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	33.91	38.58	32.98	6.29	3.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	42.30	46.69	36.75	6.24	2.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	32.58	24.23	3.70	0.96	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	29.20	38.73	29.04	4.84	3.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	37.27	43.18	36.20	4.30	3.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	31.42	24.67	4.73	1.58	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	33.48	35.63	27.58	6.12	2.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	35.18	37.84	27.66	8.85	4.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	37.47	21.79	1.91	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	28.41	34.38	24.32	6.71	3.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	35.89	31.57	32.32	4.51	1.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	29.20	38.09	9.02	1.33	0.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	29.30	38.55	25.89	5.94	2.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	32.46	36.86	29.22	8.21	3.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	28.62	35.24	9.72	1.50	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	26.63	34.76	31.67	5.33	2.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	31.45	41.87	31.96	6.84	2.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	29.90	36.10	7.84	0.91	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	26.98	33.48	24.89	5.76	3.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	36.00	46.07	34.25	7.52	4.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	37.27	25.71	1.42	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	35.12	33.93	27.38	6.94	3.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	35.31	49.81	33.21	7.95	3.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	35.04	28.62	2.28	0.21	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	38.49	46.90	37.61	10.62	3.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	34.67	41.78	30.29	8.77	4.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	35.26	32.17	6.06	1.21	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	34.74	42.40	29.29	8.34	5.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	34.70	40.87	32.39	6.17	3.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	36.45	26.13	3.27	0.52	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	41.01	41.29	26.06	9.33	4.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	33.16	44.98	31.68	8.70	2.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	31.53	21.47	2.22	0.17	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	30.18	40.98	28.56	6.51	2.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	26.92	36.78	19.19	6.13	2.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	30.00	32.91	9.13	2.07	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	30.72	35.72	26.67	5.24	2.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	31.04	34.67	23.38	4.64	1.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	29.38	27.03	7.72	1.60	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	26.20	38.43	27.95	6.64	3.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	20.25	35.36	21.46	6.04	2.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	31.70	29.13	8.20	1.96	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	41.92	57.20	54.00	10.63	3.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	27.38	43.81	32.86	9.13	4.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	27.43	23.51	4.82	1.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	28.05	41.62	34.83	5.43	4.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	36.84	42.53	27.56	6.89	3.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	25.62	46.52	13.81	2.48	1.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	31.80	47.81	36.07	10.25	4.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	36.66	36.66	26.44	4.21	2.40
Schwann Cells, donor1	11498-119F4	15.99	4.89	2.07	0.38	0.00
Schwann Cells, donor2	11578-120F3	37.43	13.61	3.40	0.00	0.00
Schwann Cells, donor3	11659-122F3	24.32	11.17	5.48	1.31	0.66
Sebocyte, donor1	11220-116B5	9.86	6.03	4.38	1.10	1.10
Sebocyte, donor2	11301-117B5	13.79	8.27	3.22	0.46	0.00
Sebocyte, donor3	11378-118B1	7.42	7.63	6.60	1.65	0.82
Sertoli Cells, donor1	11255-116F4	23.19	3.31	4.97	1.66	0.00
Sertoli Cells, donor2	11333-117F1	22.59	5.65	8.47	5.65	0.00
Skeletal Muscle Cells, donor1	11281-116I3	14.34	5.45	6.25	0.97	0.62
Skeletal Muscle Cells, donor2	11358-117H8	11.57	7.95	4.34	1.45	0.72
Skeletal Muscle Cells, donor3	11430-118G8	40.97	16.72	4.18	1.67	0.00
Skeletal Muscle Cells, donor4	11451-119A2	16.49	20.74	9.11	2.51	1.89
Skeletal Muscle Cells, donor5	11455-119A6	14.57	16.50	9.96	1.64	0.89
Skeletal Muscle Cells, donor6	11459-119B1	40.94	19.08	8.00	0.92	0.77
Skeletal Muscle Satellite Cells, donor1	11240-116D7	7.69	11.97	8.82	1.26	0.76
Skeletal Muscle Satellite Cells, donor2	11321-117D7	16.12	16.12	11.70	2.14	1.85
Skeletal Muscle Satellite Cells, donor3	11397-118D2	25.40	20.24	15.87	3.87	2.08
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	10.53	8.26	7.92	1.26	0.76
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	28.23	8.69	7.24	1.45	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	14.86	10.87	4.68	0.55	0.41
Skin - palm, donor1	10286-104F7	48.35	18.80	8.06	2.69	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	7.64	6.49	3.17	0.72	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	14.72	9.81	0.00	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	12.20	5.58	2.99	0.78	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	6.39	8.06	6.26	0.56	0.70
Small Airway Epithelial Cells, donor2	11334-117F2	5.06	7.17	6.33	1.83	0.42
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	22.84	11.84	10.57	1.06	1.06
Small Airway Epithelial Cells, donor3	11406-118E2	6.67	6.30	4.72	1.12	0.82
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	12.96	4.94	0.31	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	14.67	8.45	1.78	0.00	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	6.47	5.29	2.94	0.59	1.18
Smooth Muscle Cells - Aortic, donor1	11283-116I5	3.54	6.19	3.76	0.88	0.44
Smooth Muscle Cells - Aortic, donor2	11360-117I1	14.18	7.09	8.66	1.18	1.18
Smooth Muscle Cells - Aortic, donor3	11432-118H1	23.18	6.95	4.64	1.55	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	15.01	9.01	8.01	1.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	13.44	3.59	3.19	1.60	0.40
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	14.63	10.86	7.31	1.11	0.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	12.80	9.35	6.15	1.02	0.51
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	19.54	6.84	7.16	0.98	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	8.86	7.68	4.13	0.30	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	9.97	7.40	8.26	1.42	0.85
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	8.78	2.28	1.46	0.33	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	21.92	10.05	3.65	1.83	0.91
Smooth Muscle Cells - Carotid, donor1	11285-116I7	21.97	7.32	4.80	0.76	1.52
Smooth Muscle Cells - Carotid, donor2	11362-117I3	12.24	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	11.92	8.11	3.81	0.48	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	11.36	9.73	7.52	1.62	0.88
Smooth Muscle Cells - Colonic, donor2	11320-117D6	14.85	12.27	7.32	0.43	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	16.48	13.64	11.23	1.78	1.47
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	13.61	9.44	5.88	0.93	0.77
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	7.55	11.86	7.55	1.08	2.16
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	5.38	8.97	5.08	0.30	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	11.95	2.73	2.73	1.02	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	13.43	8.72	7.77	0.71	0.79
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	10.57	4.33	3.52	0.50	0.30
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	12.74	6.37	8.19	0.68	0.68
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	24.15	3.62	1.21	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	25.43	24.90	10.07	1.85	1.59
Smooth Muscle Cells - Prostate, donor1	11257-116F6	13.58	8.79	2.53	0.67	0.53
Smooth Muscle Cells - Prostate, donor2	11335-117F3	7.76	9.27	6.64	1.13	0.63
Smooth Muscle Cells - Prostate, donor3	11465-119B7	8.62	3.55	2.79	0.51	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	20.66	6.94	5.58	1.06	1.36
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	6.00	9.00	5.25	2.25	1.50
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	10.34	9.05	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	19.53	5.58	4.65	0.93	2.79
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	6.56	7.57	7.57	2.52	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	5.01	6.89	3.76	0.63	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	6.19	5.31	2.06	0.00	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	28.74	14.41	10.83	1.92	1.33
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	12.15	7.47	3.74	0.93	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	10.22	5.47	4.75	1.01	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	14.79	10.20	9.18	0.76	1.53
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	20.50	6.21	3.38	0.56	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	19.70	5.87	3.63	0.98	0.56
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	15.75	4.44	3.69	0.67	0.59
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	8.10	1.90	1.43	0.48	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	6.85	5.63	4.65	0.24	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	7.51	18.12	5.30	1.10	0.66
Smooth Muscle Cells - Uterine, donor3	11466-119B8	10.53	6.73	4.10	0.59	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	10.30	8.16	2.53	0.58	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	5.82	6.08	1.06	0.26	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	7.07	6.32	2.98	1.12	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	12.22	5.75	3.95	0.72	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	4.26	6.81	1.70	0.28	0.57
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	6.70	10.24	2.76	0.79	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	8.13	11.94	3.56	0.25	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	5.19	5.99	1.60	0.40	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	5.43	4.60	4.18	0.84	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	4.13	5.04	2.75	0.00	0.00
Synoviocyte, donor1	11291-117A4	9.26	7.07	6.90	0.67	1.35
Synoviocyte, donor2	11368-117I9	15.25	10.73	6.20	1.84	0.50
Synoviocyte, donor3	11440-118H9	7.37	7.37	3.57	0.67	0.45
Trabecular Meshwork Cells, donor1	11532-120A2	23.94	9.29	5.00	1.07	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	7.93	3.96	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	9.96	3.01	5.33	1.62	0.93
Tracheal Epithelial Cells, donor1	11292-117A5	17.63	5.23	4.52	0.93	0.57
Tracheal Epithelial Cells, donor2	11369-118A1	14.30	6.19	5.03	1.93	0.77
Tracheal Epithelial Cells, donor3	11441-118I1	12.03	6.30	2.86	0.00	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	12.92	11.93	11.32	1.48	0.98
Urethra, donor2	10319-105A4	23.38	23.38	16.19	5.40	0.00
Urothelial Cells, donor1	11520-119H8	5.58	3.45	1.59	0.27	0.27
Urothelial Cells, donor2	11600-120H7	6.41	5.21	4.01	0.00	0.00
Urothelial Cells, donor3	11681-122H7	6.42	4.58	3.90	0.69	0.46
Urothelial cells, donor0	11216-116B1	16.72	4.68	3.57	0.45	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	30.25	4.45	0.00	1.78	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	45.75	7.15	5.72	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	22.59	6.85	2.74	0.68	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	5.51	9.64	6.54	0.69	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	9.30	8.13	10.46	1.16	1.16
Whole blood (ribopure), donor090612, donation1	12182-129A4	22.91	9.37	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	22.03	4.59	0.92	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	18.26	5.48	8.22	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	18.75	15.54	15.54	2.10	1.23
Wilms' tumor cell line:HFWT	10597-108E3	12.32	13.20	6.16	3.52	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	22.90	15.36	14.52	4.19	1.40
achilles tendon, donor2	10292-104G4	14.47	10.33	8.27	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	8.67	19.38	15.55	4.08	2.04
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	21.82	37.84	34.83	8.36	6.97
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	36.44	25.17	16.98	3.44	1.90
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	14.42	30.20	25.85	3.81	3.81
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	34.85	32.89	21.92	4.50	1.12
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	26.01	39.12	29.61	6.13	3.17
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	39.47	17.42	11.43	1.36	1.63
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	22.47	44.06	20.71	1.76	0.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	45.33	15.93	8.98	0.82	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	53.97	30.68	18.25	5.82	2.72
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	25.02	23.37	13.43	2.21	0.55
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	11.70	54.61	15.60	3.90	7.80
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	33.70	33.70	17.43	4.65	1.39
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	50.23	26.93	16.57	2.85	1.04
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	46.47	23.96	13.74	3.21	1.46
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	32.53	22.77	9.30	1.86	0.93
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	24.68	24.26	18.92	2.88	1.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	3.68	3.68	1.84	0.92	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	12.37	22.62	17.92	1.28	2.99
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	9.10	20.32	15.77	1.82	1.52
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	16.37	19.74	17.57	2.17	2.17
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	29.85	22.50	11.81	3.56	2.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	32.02	21.01	8.67	1.33	1.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	44.60	24.16	13.01	1.86	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	44.45	19.21	13.18	2.26	1.13
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	79.38	13.52	7.85	0.87	0.87
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	22.49	11.25	7.50	1.87	0.00
adenocarcinoma cell line:IM95m	10796-110I4	20.96	11.77	7.54	2.59	0.94
adipose tissue, adult, pool1	10010-101C1	11.79	7.76	7.60	1.09	0.93
adipose, donor1	10184-103D4	35.18	22.87	16.42	2.35	2.93
adipose, donor2	10185-103D5	19.87	11.35	5.68	2.03	0.00
adipose, donor3	10186-103D6	13.07	14.16	12.80	2.72	2.45
adipose, donor4	10187-103D7	27.74	11.27	7.80	6.07	1.73
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	44.35	14.68	11.36	3.47	2.05
adrenal gland, adult, pool1	10081-102A9	10.91	21.83	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	22.28	17.48	16.01	2.53	2.67
alveolar cell carcinoma cell line:SW 1573	10708-109H6	22.15	14.65	11.08	1.07	2.14
amniotic membrane cells, donor1	12235-129G3	12.29	20.40	11.59	0.93	0.93
amniotic membrane cells, donor2	12236-129G4	31.78	11.16	12.51	2.37	2.37
amniotic membrane cells, donor3	12237-129G5	26.81	16.79	14.14	1.77	1.18
amygdala - adult, donor10196	10167-103B5	10.67	2.37	1.19	2.37	1.19
amygdala, adult, donor10252	10151-102I7	25.35	7.91	5.68	1.22	1.22
amygdala, newborn, donor10223	10360-105E9	20.98	12.91	4.84	2.26	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	11.21	10.70	8.91	2.16	1.02
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	20.96	14.12	11.91	1.54	1.32
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	28.39	31.40	28.39	4.34	2.34
aorta, adult, pool1	10052-101G7	17.46	10.20	5.49	0.59	0.00
appendix, adult	10189-103D9	20.18	17.47	7.37	2.72	1.16
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	18.57	21.67	18.57	3.78	2.41
artery, adult	10190-103E1	16.30	9.51	5.43	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	41.72	7.39	7.39	0.87	0.58
b cell line:RPMI1788	10427-106D4	14.13	29.59	21.56	3.87	3.27
basal cell carcinoma cell line:TE 354.T	10702-109G9	9.71	6.10	8.60	1.39	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	20.04	26.79	19.65	4.86	2.58
bile duct carcinoma cell line:TFK-1	10496-107C1	13.89	23.60	19.08	4.02	1.67
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	14.54	15.10	12.86	1.12	0.56
bladder, adult, pool1	10011-101C2	24.55	9.13	7.71	0.87	0.43
blood, adult, pool1	10053-101G8	8.86	2.21	8.86	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	14.56	11.99	6.85	0.00	0.00
bone marrow, adult	10192-103E3	8.77	17.55	11.47	2.02	0.00
brain, adult, donor1	10084-102B3	20.50	5.13	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	19.04	6.01	3.45	0.56	0.45
brain, fetal, pool1	10085-102B4	48.09	5.34	2.67	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	7.27	26.43	20.81	1.65	2.97
breast carcinoma cell line:MDA-MB-453	10419-106C5	17.85	31.21	20.60	4.74	2.50
breast, adult, donor1	10080-102A8	6.31	4.42	3.16	0.63	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	26.80	18.55	11.18	1.91	1.52
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	28.76	25.67	24.43	3.71	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	42.82	10.36	8.52	0.46	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	20.58	9.68	11.86	2.66	0.97
carcinoid cell line:NCI-H1770	10703-109H1	30.09	15.99	11.28	2.82	0.94
carcinoid cell line:NCI-H727	10735-110B6	13.34	7.88	5.25	0.66	0.66
carcinoid cell line:SK-PN-DW	10719-109I8	16.16	26.94	21.55	3.49	2.54
carcinosarcoma cell line:JHUCS-1	10642-109A3	14.64	26.88	19.16	2.13	1.60
caudate nucleus - adult, donor10196	10177-103C6	11.51	3.45	3.45	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	19.24	11.55	9.04	0.67	2.01
caudate nucleus, adult, donor10258	10379-105H1	12.23	12.23	8.41	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	12.82	19.78	15.02	4.03	2.56
cerebellum - adult, donor10196	10173-103C2	34.96	5.83	5.83	0.00	2.91
cerebellum, adult, donor10252	10166-103B4	34.59	11.32	8.97	1.71	1.07
cerebellum, adult, pool1	10083-102B2	19.32	3.45	3.10	0.34	0.00
cerebellum, newborn, donor10223	10357-105E6	43.17	30.72	21.59	1.66	1.66
cerebral meninges, adult	10188-103D8	31.52	14.88	9.58	1.76	0.25
cerebrospinal fluid, donor2	10294-104G6	10.23	8.04	8.77	0.73	0.00
cervical cancer cell line:D98-AH2	10552-107I3	24.16	18.26	12.80	3.02	1.73
cervical cancer cell line:ME-180	10553-107I4	12.76	27.18	23.20	4.64	3.31
cervix, adult, pool1	10013-101C4	29.29	7.87	8.19	0.73	1.05
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	7.38	16.58	10.17	1.81	1.81
chondrosarcoma cell line:SW 1353	10700-109G7	11.76	5.23	5.23	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	18.64	9.57	7.58	1.12	0.87
choriocarcinoma cell line:SCH	10785-110H2	10.47	10.23	9.36	0.86	0.62
choriocarcinoma cell line:T3M-3	10618-108G6	16.84	14.23	9.96	0.95	0.47
chorionic membrane cells, donor1	12238-129G6	12.82	26.78	19.94	3.42	1.99
chorionic membrane cells, donor2	12239-129G7	21.18	14.52	10.84	2.49	0.80
chorionic membrane cells, donor3	12240-129G8	29.12	30.77	19.78	2.75	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	12.12	78.76	31.30	5.05	2.02
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	26.51	11.53	9.41	1.73	1.92
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	21.96	8.45	8.03	2.11	0.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	44.17	9.50	5.91	1.80	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	35.31	10.16	6.29	0.97	0.73
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	30.95	11.81	3.05	2.24	0.81
chronic myelogenous leukemia cell line:K562	10454-106G4	35.63	10.01	7.95	3.53	1.18
chronic myelogenous leukemia cell line:KU812	10409-106B4	15.64	35.71	32.84	5.99	2.87
clear cell carcinoma cell line:JHOC-5	10638-108I8	56.00	16.69	15.31	3.66	1.83
clear cell carcinoma cell line:TEN	10636-108I6	7.63	20.13	13.36	2.95	1.74
colon carcinoma cell line:CACO-2	10513-107D9	17.21	25.44	20.68	5.13	2.75
colon carcinoma cell line:COLO-320	10420-106C6	33.45	11.02	15.20	0.76	2.28
colon, adult, donor1	10082-102B1	8.33	10.71	7.14	0.00	0.00
colon, adult, pool1	10014-101C5	17.98	12.57	8.93	2.23	1.29
colon, fetal, donor1	10070-101I7	18.54	3.71	4.94	1.24	0.62
common myeloid progenitor CMP, donor1	12130-128D6	100.84	18.33	27.50	4.58	0.00
common myeloid progenitor CMP, donor2	12134-128E1	125.18	25.04	50.07	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	12.75	26.35	21.67	5.10	1.70
cord blood derived cell line:COBL-a 24h infection	10453-106G3	22.19	14.34	10.72	2.87	1.96
cord blood derived cell line:COBL-a untreated	10449-106F8	25.24	17.77	14.38	2.82	1.27
corpus callosum, adult, pool1	10042-101F6	19.13	9.29	7.63	1.44	0.44
cruciate ligament, donor2	10295-104G7	11.35	12.16	4.86	0.81	0.00
diaphragm, fetal, donor1	10069-101I6	6.42	3.21	6.42	2.41	1.61
diencephalon, adult	10193-103E4	13.68	3.84	3.12	0.00	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	12.40	35.36	27.55	6.20	2.53
ductal cell carcinoma cell line:KLM-1	10438-106E6	29.23	20.00	16.16	2.31	2.82
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	6.98	14.92	11.55	2.65	1.20
ductus deferens, adult	10196-103E7	6.98	14.45	8.97	1.99	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	5.76	10.08	2.88	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	21.33	19.13	6.62	0.74	0.74
dura mater, adult, donor1	10041-101F5	11.81	5.62	6.61	1.32	0.58
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	19.99	37.09	31.53	5.11	5.55
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	27.51	24.65	20.63	5.02	1.72
embryonic pancreas cell line:1B2C6	10604-108F1	32.68	12.33	6.78	3.08	1.23
embryonic pancreas cell line:1C3D3	10605-108F2	40.56	12.71	5.75	1.51	0.61
embryonic pancreas cell line:1C3IKEI	10606-108F3	31.18	10.19	11.42	3.40	0.93
embryonic pancreas cell line:2C6	10603-108E9	43.34	9.19	5.25	2.63	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	44.92	13.41	8.04	2.01	1.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	21.75	5.44	5.80	0.91	0.72
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	9.65	28.95	21.23	3.38	3.38
epidermoid carcinoma cell line:A431	10426-106D3	31.24	22.90	21.23	3.11	2.33
epidermoid carcinoma cell line:Ca Ski	10431-106D8	24.42	23.21	18.70	2.75	3.30
epididymis, adult	10197-103E8	10.26	8.58	6.07	1.05	0.84
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	21.47	8.52	6.39	0.71	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	8.26	11.80	8.65	1.18	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	12.32	34.07	31.19	7.60	4.59
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	14.17	29.13	23.42	7.18	2.56
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	13.67	34.06	28.34	7.84	3.25
esophagus, adult, pool1	10015-101C6	23.89	13.80	10.62	1.38	0.74
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	14.90	13.28	10.02	1.88	0.75
eye - muscle inferior rectus, donor1	10272-104E2	19.32	7.24	4.83	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	16.83	4.21	6.31	4.21	0.00
eye - muscle medial, donor2	10299-104H2	17.86	13.39	4.46	0.00	0.00
eye - muscle superior, donor2	10297-104G9	19.49	16.05	4.59	1.15	0.00
eye - vitreous humor, donor1	10268-104D7	20.40	14.57	4.37	1.46	0.00
eye, fetal, donor1	10054-101G9	33.81	6.10	7.37	0.25	1.02
fibrosarcoma cell line:HT-1080	10758-110E2	20.77	6.28	5.26	0.64	0.51
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	24.93	15.43	8.55	2.14	1.90
frontal lobe, adult, pool1	10040-101F4	20.36	2.91	2.91	0.84	0.47
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	13.81	20.12	18.62	2.10	2.10
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	37.49	16.18	13.62	2.38	1.65
gall bladder, adult	10198-103E9	6.28	11.83	6.28	0.48	0.72
gamma delta positive T cells, donor1	11937-126A2	36.51	11.81	5.37	1.61	0.00
gamma delta positive T cells, donor2	11938-126A3	20.17	8.22	4.86	0.75	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	12.67	9.93	8.24	1.06	0.84
gastric adenocarcinoma cell line:MKN45	10612-108F9	10.25	22.63	14.12	2.51	1.16
gastric cancer cell line:AZ521	10549-107H9	42.30	20.82	19.84	3.61	1.97
gastric cancer cell line:GSS	10560-108A2	48.51	17.39	9.15	1.83	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	13.25	35.18	23.99	3.43	3.20
giant cell carcinoma cell line:LU65	10487-107B1	13.20	26.28	21.57	5.39	2.52
giant cell carcinoma cell line:Lu99B	10433-106E1	13.58	10.64	8.12	1.12	0.70
glassy cell carcinoma cell line:HOKUG	10688-109F4	15.96	15.96	13.47	2.74	2.24
glioblastoma cell line:A172, tech_rep1	10444-106F3	21.74	14.88	11.29	1.79	0.74
glioblastoma cell line:A172, tech_rep2	10444-106F3	17.41	14.04	10.39	2.81	2.53
glioblastoma cell line:T98G	10485-107A8	22.41	10.26	7.73	2.10	1.43
glioma cell line:GI-1	10413-106B8	12.01	13.18	6.15	1.17	0.88
globus pallidus - adult, donor10196	10175-103C4	6.56	5.83	2.19	0.73	0.73
globus pallidus, adult, donor10252	10161-103A8	13.43	10.50	10.74	2.20	0.73
globus pallidus, adult, donor10258	10367-105F7	4.11	8.22	4.11	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	17.59	18.65	8.53	3.73	1.60
granulocyte macrophage progenitor, donor1	12131-128D7	102.78	80.76	61.18	9.79	4.89
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	10.93	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	94.08	15.68	20.91	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	12.48	7.36	6.40	2.24	0.00
hIPS +CCl2, biol_rep1	14383-156B9	36.27	16.07	0.00	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	42.98	13.72	0.00	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	39.29	9.02	0.00	0.00	0.00
hIPS, biol_rep1	14380-156B6	66.12	12.94	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	29.49	10.97	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	8.83	6.62	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	13.79	18.96	12.64	2.01	1.44
heart - mitral valve, adult	10205-103F7	15.85	11.06	15.25	3.89	0.30
heart - pulmonic valve, adult	10206-103F8	17.52	6.01	6.28	1.05	0.00
heart - tricuspid valve, adult	10207-103F9	22.48	15.82	15.82	2.50	2.50
heart, adult, diseased post-infarction, donor1	10050-101G5	11.22	12.86	5.51	1.84	0.20
heart, adult, diseased, donor1	10051-101G6	15.33	3.41	2.13	0.43	0.43
heart, adult, pool1	10016-101C7	20.01	7.13	7.59	1.15	1.38
heart, fetal, pool1	10046-101G1	31.63	8.63	8.11	0.72	0.62
hepatic mesenchymal tumor cell line:LI90	10778-110G4	6.79	5.86	3.70	0.31	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	20.22	26.16	24.97	7.14	3.57
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	21.99	38.56	35.25	8.18	4.64
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	28.40	40.66	37.26	8.37	5.70
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	23.65	39.41	36.58	9.70	5.05
hepatoma cell line:Li-7	10484-107A7	8.34	18.46	14.35	3.78	2.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	34.07	26.23	18.49	3.12	1.71
hippocampus - adult, donor10196	10169-103B7	13.25	7.57	0.95	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	20.61	8.98	10.00	1.84	1.02
hippocampus, adult, donor10258	10374-105G5	22.91	5.98	0.50	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	28.90	13.39	8.11	3.17	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	43.33	47.00	26.86	1.83	3.66
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	29.06	26.90	21.21	3.93	1.57
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	30.98	30.47	20.57	2.79	1.02
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	15.79	18.04	7.89	1.69	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	19.11	19.62	14.98	1.81	0.77
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	30.37	19.74	8.73	2.28	1.14
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	18.39	22.48	15.47	2.34	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	15.73	18.10	17.67	1.51	1.51
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	20.02	20.85	14.18	2.92	1.67
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	15.87	37.18	21.31	2.60	2.60
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	16.07	27.48	24.11	3.38	1.77
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	23.57	28.28	20.87	3.37	2.02
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	34.11	26.76	19.40	3.44	2.82
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	38.32	20.14	11.79	2.46	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	68.95	20.95	12.22	5.24	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	31.31	15.08	10.50	1.91	1.34
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	24.86	12.21	10.90	1.31	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	24.49	15.99	7.00	2.50	1.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	30.90	9.42	10.36	1.32	1.32
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	30.92	10.91	4.09	1.36	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	28.82	10.34	6.89	1.25	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	19.76	17.15	12.08	2.45	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	18.58	13.35	10.74	1.45	0.58
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	18.23	16.14	8.37	0.60	1.49
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	49.14	26.97	19.40	3.33	1.85
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	43.93	20.54	12.84	1.43	2.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	62.06	34.30	16.33	3.27	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	29.22	17.96	10.56	2.82	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	26.61	12.04	12.04	1.58	1.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	44.79	20.28	9.68	1.21	0.61
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	30.51	18.10	12.41	3.10	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	42.51	22.58	11.29	1.33	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	37.45	26.68	16.93	5.13	2.05
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	23.78	28.89	12.78	3.83	1.02
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	48.46	29.53	15.90	4.54	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	25.20	22.85	15.46	3.02	1.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	47.58	23.43	16.66	2.17	1.93
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	55.26	25.40	12.92	2.67	3.12
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	53.66	22.93	16.59	2.44	1.95
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	34.84	16.20	7.95	0.92	1.22
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	81.33	58.56	16.27	13.01	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	42.69	19.19	10.92	3.31	0.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	30.65	24.63	15.32	2.19	1.64
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	33.66	19.18	10.49	3.62	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	41.99	15.66	8.90	1.78	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	31.03	20.29	14.32	1.19	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	28.98	20.86	14.63	3.79	0.81
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	22.63	27.48	9.70	2.96	1.35
immature langerhans cells, donor1	11904-125F5	24.21	40.68	16.95	2.18	1.70
immature langerhans cells, donor2	11905-125F6	41.19	21.39	21.39	2.38	2.38
insula, adult, pool1	10039-101F3	23.00	4.92	4.07	0.66	0.28
keratoacanthoma cell line:HKA-1	10791-110H8	9.75	17.23	10.08	1.95	0.33
kidney, adult, pool1	10017-101C8	16.72	10.51	11.41	0.80	0.50
kidney, fetal, pool1	10045-101F9	26.10	11.53	11.03	2.05	0.85
large cell lung carcinoma cell line:IA-LM	10509-107D5	32.38	12.92	13.92	2.84	1.42
large cell lung carcinoma cell line:NCI-H460	10839-111E2	15.07	12.99	8.71	1.66	2.21
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	17.80	16.70	10.28	2.20	1.83
left atrium, adult, donor1	10079-102A7	9.26	3.27	1.09	0.54	0.00
left ventricle, adult, donor1	10078-102A6	11.63	2.53	1.52	0.51	0.51
leiomyoblastoma cell line:G-402	10721-110A1	30.92	10.40	8.48	1.37	1.09
leiomyoma cell line:10964C	10569-108B2	6.83	11.14	3.95	0.72	0.36
leiomyoma cell line:15242A	10570-108B3	13.04	7.07	3.26	1.09	0.00
leiomyoma cell line:15425	10571-108B4	10.93	9.23	8.26	1.70	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	31.75	6.35	19.05	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	18.82	11.50	8.36	3.14	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	24.67	22.08	18.89	4.72	1.53
liposarcoma cell line:KMLS-1	10782-110G8	18.59	7.81	3.12	1.25	0.62
liposarcoma cell line:SW 872	10726-110A6	38.87	10.11	7.31	1.22	0.97
liver, adult, pool1	10018-101C9	9.89	8.10	6.32	0.49	0.32
liver, fetal, pool1	10086-102B5	4.70	7.53	3.76	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	10.65	6.56	7.15	0.87	0.87
locus coeruleus, adult, donor10252	10165-103B3	10.70	8.67	6.27	0.92	0.55
locus coeruleus, adult, donor10258	10375-105G6	5.64	2.54	1.69	1.41	0.00
locus coeruleus, newborn, donor10223	10362-105F2	13.46	20.19	8.41	1.26	0.42
lung adenocarcinoma cell line:A549	10499-107C4	10.52	8.17	5.81	2.08	1.11
lung adenocarcinoma cell line:PC-14	10408-106B3	18.61	13.79	13.10	0.69	2.07
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	28.87	15.95	10.94	1.32	1.19
lung, adult, pool1	10019-101D1	14.65	9.57	7.44	1.42	0.95
lung, fetal, donor1	10068-101I5	26.83	12.56	5.42	0.57	0.00
lung, right lower lobe, adult, donor1	10075-102A3	14.66	5.04	4.12	0.46	0.00
lymph node, adult, donor1	10077-102A5	8.99	4.26	3.31	0.47	0.47
lymphangiectasia cell line:DS-1	10727-110A7	19.73	16.22	8.33	0.66	1.32
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	11.92	23.39	19.17	4.83	1.66
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	22.09	33.98	37.38	2.55	0.85
mature adipocyte, donor1	12231-129F8	14.65	15.10	11.54	1.78	1.78
mature adipocyte, donor2	12232-129F9	17.85	12.45	11.41	2.49	1.25
mature adipocyte, donor3	12233-129G1	18.49	17.78	15.41	2.84	0.95
mature adipocyte, donor4	12234-129G2	18.69	9.21	7.11	1.84	0.53
maxillary sinus tumor cell line:HSQ-89	10414-106B9	16.44	11.44	10.01	2.62	1.43
medial frontal gyrus - adult, donor10196	10170-103B8	25.94	1.13	4.51	1.13	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	20.41	7.17	6.07	1.29	1.10
medial frontal gyrus, adult, donor10258	10368-105F8	7.31	5.08	0.00	0.32	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	26.02	22.60	9.81	0.85	1.71
medial temporal gyrus - adult, donor10196	10183-103D3	15.86	4.39	3.38	0.84	0.51
medial temporal gyrus, adult, donor10252	10156-103A3	23.98	8.91	9.34	0.42	1.27
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	21.19	3.85	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	14.35	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	17.59	17.23	6.82	2.15	0.72
medulla oblongata - adult, donor10196	10174-103C3	7.79	7.14	3.24	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	13.47	7.43	6.66	1.55	1.70
medulla oblongata, adult, pool1	10038-101F2	14.69	6.37	5.47	0.73	0.65
medulla oblongata, newborn, donor10223	10361-105F1	15.28	12.85	11.80	1.39	0.35
medulloblastoma cell line:D283 Med	10838-111E1	75.94	35.65	29.67	4.43	1.77
medulloblastoma cell line:ONS-76	10759-110E3	23.97	11.86	9.05	2.81	1.10
melanoma cell line:COLO 679	10514-107E1	15.96	10.21	7.33	0.86	0.86
melanoma cell line:G-361	10465-106H6	10.86	12.49	8.42	1.63	1.90
meningioma cell line:HKBMM	10691-109F7	17.01	12.12	9.41	2.53	1.27
merkel cell carcinoma cell line:MKL-1	10843-111E6	93.40	63.44	52.87	8.81	2.64
merkel cell carcinoma cell line:MS-1	10844-111E7	52.62	60.66	47.18	13.22	5.96
mesenchymal precursor cell - adipose, donor1	11747-123G1	23.78	14.27	9.21	1.07	1.07
mesenchymal precursor cell - adipose, donor2	11748-123G2	10.54	9.45	5.82	1.27	1.27
mesenchymal precursor cell - adipose, donor3	11749-123G3	15.32	6.21	1.66	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	10.25	10.96	5.90	1.12	0.42
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	13.09	8.86	5.39	1.73	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	20.13	9.72	4.16	2.78	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	4.46	6.35	4.12	0.51	0.51
mesenchymal precursor cell - cardiac, donor2	11753-123G7	10.24	12.08	7.94	1.73	0.92
mesenchymal precursor cell - cardiac, donor3	11754-123G8	22.28	8.89	4.51	0.93	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	11.61	11.48	6.08	1.49	0.81
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	12.38	11.81	6.97	1.00	0.43
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	12.19	4.28	1.98	0.66	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	15.77	10.65	6.37	0.69	0.69
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	19.20	11.87	5.93	1.75	1.05
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	13.07	3.47	2.65	0.61	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	20.13	8.99	3.24	0.72	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	10.24	6.10	3.41	0.41	0.21
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	8.21	6.61	5.47	0.91	0.46
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	20.56	15.94	7.13	0.84	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	11.66	13.15	7.32	0.90	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	12.60	9.28	5.69	0.96	0.35
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	14.36	8.10	2.58	0.74	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	15.74	4.86	3.72	1.14	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	20.21	21.05	16.84	5.47	0.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	10.50	5.02	5.94	1.83	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	11.77	4.09	1.28	0.51	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	11.52	4.71	5.76	1.05	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	14.17	8.32	2.16	0.92	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	13.89	5.88	2.82	0.94	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	13.88	5.08	3.05	0.68	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	13.36	7.07	3.14	1.18	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	12.97	5.56	0.93	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	96.61	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	16.44	5.77	4.04	1.44	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	14.06	6.25	2.45	1.12	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	13.22	8.17	3.36	1.44	0.48
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	16.87	6.60	6.60	0.73	1.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	11.41	6.71	3.36	0.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	14.33	5.73	2.87	0.82	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	17.18	10.31	3.87	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	10.94	16.41	0.00	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	41.32	10.33	5.16	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	12.67	8.12	3.57	0.65	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	8.73	8.73	5.82	1.45	2.91
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	12.79	7.46	6.40	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	22.90	8.18	6.54	0.00	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	12.05	9.33	5.05	0.00	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	12.59	6.30	2.10	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	16.89	7.95	2.98	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	9.53	0.00	9.53	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	10.67	10.67	2.37	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	12.18	6.09	3.66	0.00	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	13.30	7.60	3.80	0.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	11.38	5.17	3.79	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	8.60	8.60	4.30	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	11.98	7.98	3.99	3.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	13.78	6.89	3.44	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	13.04	5.70	2.04	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	9.53	3.18	3.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	8.84	5.90	2.95	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	12.16	4.99	3.12	0.31	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	8.02	10.69	2.67	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	14.19	5.91	3.55	3.55	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	25.68	10.27	2.57	0.00	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	14.46	10.33	2.75	1.38	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	6.43	6.93	1.98	0.49	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	11.22	7.85	4.49	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	11.45	3.18	2.54	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	6.45	4.84	2.82	1.21	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	10.90	8.72	4.36	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	3.80	5.07	7.60	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	4.86	6.68	0.61	1.21	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	0.00	4.52	4.52	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	4.12	3.29	2.47	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	7.94	6.35	3.37	0.99	0.60
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	9.09	3.24	2.27	0.00	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	9.17	9.17	5.09	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	17.80	12.38	9.28	0.77	2.32
mesothelioma cell line:ACC-MESO-1	10493-107B7	24.81	13.47	8.50	1.42	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	17.61	9.04	6.26	1.62	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	17.09	12.82	12.82	4.27	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	15.72	13.05	14.49	2.57	1.03
mesothelioma cell line:Mero-25	10850-111F4	12.48	15.43	6.81	1.82	0.68
mesothelioma cell line:Mero-41	10851-111F5	39.12	14.18	8.56	0.73	0.49
mesothelioma cell line:Mero-48a	10852-111F6	21.48	9.96	4.43	0.66	0.89
mesothelioma cell line:Mero-82	10853-111F7	9.20	16.03	8.94	1.84	0.53
mesothelioma cell line:Mero-83	10854-111F8	23.49	18.72	7.83	2.04	0.68
mesothelioma cell line:Mero-84	10855-111F9	14.66	24.52	12.89	1.52	0.76
mesothelioma cell line:Mero-95	10856-111G1	22.77	10.35	8.28	0.41	0.62
mesothelioma cell line:NCI-H2052	10847-111F1	19.55	13.42	10.27	1.82	0.66
mesothelioma cell line:NCI-H226	10846-111E9	9.05	15.38	10.86	0.72	1.63
mesothelioma cell line:NCI-H2452	10848-111F2	12.47	11.62	7.17	1.54	0.85
mesothelioma cell line:NCI-H28	10845-111E8	22.14	22.65	12.47	3.56	1.78
mesothelioma cell line:No36	10857-111G2	30.66	20.55	15.66	1.96	0.98
mesothelioma cell line:ONE58	10858-111G3	16.80	26.01	19.78	2.44	1.35
migratory langerhans cells, donor1	11901-125F2	24.95	6.91	3.84	0.77	0.00
migratory langerhans cells, donor2	11902-125F3	25.89	6.23	2.93	0.24	0.00
migratory langerhans cells, donor3	11903-125F4	30.15	10.23	4.67	0.90	0.90
mixed mullerian tumor cell line:HTMMT	10689-109F5	20.89	12.08	9.79	0.98	0.65
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	50.65	15.68	11.23	1.70	1.27
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	4.38	13.82	9.68	2.07	1.15
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	14.08	14.84	8.37	2.85	1.33
myelodysplastic syndrome cell line:SKM-1	10772-110F7	31.60	26.61	21.07	3.88	3.33
myeloma cell line:PCM6	10474-106I6	11.27	17.99	10.28	1.58	1.19
myxofibrosarcoma cell line:MFH-ino	10600-108E6	15.22	13.70	9.13	0.51	1.01
myxofibrosarcoma cell line:NMFH-1	10684-109E9	35.31	16.67	8.04	1.57	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	11.37	3.90	4.90	0.67	0.22
nasal epithelial cells, donor1, tech_rep2	12226-129F3	14.93	4.56	3.90	0.74	0.22
nasal epithelial cells, donor2	12227-129F4	11.04	4.97	3.31	0.55	0.55
neuroblastoma cell line:CHP-134	10508-107D4	72.47	24.85	23.93	3.91	2.53
neuroblastoma cell line:NB-1	10539-107G8	50.14	20.77	17.21	2.81	2.06
neuroblastoma cell line:NBsusSR	10607-108F4	38.38	13.50	8.22	1.48	0.63
neuroblastoma cell line:NH-12	10555-107I6	58.51	19.38	12.30	1.30	1.49
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	14.71	12.57	8.54	2.61	1.42
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	26.29	13.78	12.67	2.06	1.11
neuroectodermal tumor cell line:TASK1	10774-110F9	30.39	8.45	6.44	1.41	0.81
neuroepithelioma cell line:SK-N-MC	10728-110A8	10.81	9.54	6.99	0.64	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	8.78	3.19	3.19	1.06	0.53
neutrophil PMN, donor1	12133-128D9	59.50	44.62	14.87	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	13.28	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	9.47	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	51.92	32.47	26.89	4.74	3.38
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	33.62	54.43	36.82	6.40	4.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	20.52	8.34	7.37	1.92	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	14.19	11.82	13.14	2.63	0.26
nucleus accumbens, adult, pool1	10037-101F1	16.31	3.75	4.22	0.84	0.66
occipital cortex - adult, donor10196	10172-103C1	22.66	6.18	2.06	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	26.03	8.86	9.66	2.15	1.61
occipital cortex, newborn, donor10223	10355-105E4	32.75	12.37	8.37	1.09	1.82
occipital lobe, adult, donor1	10076-102A4	12.86	6.30	3.15	1.05	0.79
occipital lobe, fetal, donor1	10073-102A1	20.60	3.86	1.29	0.43	0.00
occipital pole, adult, pool1	10036-101E9	18.13	3.39	3.23	0.47	0.47
olfactory region, adult	10195-103E6	21.02	6.11	3.82	0.76	0.76
optic nerve, donor1	10277-104E7	22.01	8.00	6.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	2.73	12.64	11.05	4.10	0.91
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	53.03	40.25	28.71	8.66	3.16
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	23.03	19.64	19.13	2.88	1.52
oral squamous cell carcinoma cell line:SAS	10544-107H4	32.11	23.10	12.36	1.85	1.27
osteoclastoma cell line:Hs 706.T	10704-109H2	4.41	7.64	3.53	0.29	0.88
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	20.56	21.49	8.41	0.00	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	4.45	12.51	6.79	1.27	0.64
ovary, adult, pool1	10020-101D2	33.54	11.27	9.61	1.75	1.22
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	12.65	13.38	9.53	1.83	0.73
pancreas, adult, donor1	10049-101G4	11.29	6.58	4.70	0.00	1.88
pancreatic carcinoma cell line:NOR-P1	10698-109G5	5.59	20.69	12.02	2.80	2.52
papillary adenocarcinoma cell line:8505C	10437-106E5	17.89	19.76	15.50	3.75	1.02
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	14.74	18.05	13.74	1.49	0.99
paracentral gyrus, adult, pool1	10035-101E8	16.38	3.57	3.48	0.55	0.46
parietal cortex, adult, donor10258	10373-105G4	8.81	6.61	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	22.57	8.46	0.94	0.94	0.94
parietal lobe, adult, donor10252	10157-103A4	21.09	6.56	4.85	1.14	0.86
parietal lobe, adult, pool1	10034-101E7	17.54	4.58	4.49	0.44	0.09
parietal lobe, fetal, donor1	10072-101I9	22.31	10.67	5.82	0.97	0.00
parietal lobe, newborn, donor10223	10356-105E5	28.04	21.31	7.85	1.87	1.12
parotid gland, adult	10199-103F1	10.48	6.17	6.78	0.00	0.62
penis, adult	10200-103F2	31.15	5.91	2.69	0.54	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	26.03	13.20	8.37	1.49	0.74
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	17.34	19.38	13.55	3.64	1.46
pineal gland - adult, donor10196	10179-103C8	27.09	16.13	7.10	1.94	0.00
pineal gland, adult, donor10252	10160-103A7	22.50	5.92	6.51	1.18	0.59
pineal gland, adult, donor10258	10377-105G8	11.91	14.42	10.03	2.51	0.00
pituitary gland - adult, donor10196	10180-103C9	39.46	15.18	4.05	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	37.52	14.59	8.86	2.61	0.00
pituitary gland, adult, donor10258	10378-105G9	15.32	15.32	8.51	1.70	0.00
placenta, adult, pool1	10021-101D3	16.66	18.28	16.99	2.58	1.83
plasma cell leukemia cell line:ARH-77	10840-111E3	19.07	28.47	19.47	3.58	3.71
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	8.25	10.27	6.85	1.40	0.47
pons, adult, pool1	10033-101E6	11.79	2.67	3.01	0.26	0.60
postcentral gyrus, adult, pool1	10032-101E5	21.18	3.14	3.23	0.61	0.52
promyelocytes/myelocytes PMC, donor1	12132-128D8	52.28	25.10	16.73	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	71.60	5.51	22.03	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	117.36	0.00	11.74	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	30.88	15.88	11.36	2.48	1.17
prostate cancer cell line:PC-3	10439-106E7	48.82	22.51	20.15	3.45	2.54
prostate, adult, pool1	10022-101D4	23.76	9.52	5.62	0.73	0.82
putamen, adult, donor10196	10176-103C5	18.65	6.37	8.73	1.42	0.71
putamen, adult, donor10252	10152-102I8	17.65	19.61	1.96	3.92	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	27.32	10.93	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	9.91	8.21	2.90	0.24	1.45
putamen, newborn, donor10223	10365-105F5	12.74	11.24	6.00	3.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	27.35	24.15	15.71	3.49	1.75
rectum, fetal, donor1	10067-101I4	18.08	6.95	8.35	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	13.99	10.81	10.81	1.27	1.91
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	43.49	5.80	4.14	0.83	0.00
retina, adult, pool1	10030-101E3	16.60	7.06	5.37	0.70	0.40
retinoblastoma cell line:Y79	10475-106I7	92.49	24.68	21.04	3.64	3.38
rhabdomyosarcoma cell line:KYM-1	10787-110H4	32.34	11.80	10.20	2.09	1.23
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	28.12	29.24	25.03	6.75	2.53
sacrococcigeal teratoma cell line:HTST	10695-109G2	12.88	13.64	4.55	4.55	0.00
salivary acinar cells, donor1	11771-123I7	17.48	8.90	5.18	1.13	0.97
salivary acinar cells, donor2	11772-123I8	22.58	7.99	5.92	0.55	0.96
salivary acinar cells, donor3	11773-123I9	16.55	11.25	6.62	1.99	0.66
salivary gland, adult, pool1	10093-102C3	12.01	5.15	2.86	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	32.88	8.35	7.34	1.35	0.76
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	33.62	8.23	6.70	1.41	1.29
seminal vesicle, adult	10201-103F3	16.93	16.93	16.93	1.06	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	75.31	37.90	24.78	5.10	2.19
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	32.21	16.10	9.06	2.01	0.75
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	35.12	11.04	13.05	2.01	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	12.49	25.39	18.80	2.82	1.75
signet ring carcinoma cell line:Kato III	10436-106E4	7.85	24.10	18.68	4.53	1.88
signet ring carcinoma cell line:NUGC-4	10483-107A6	22.58	12.00	8.13	3.74	1.16
skeletal muscle - soleus muscle, donor1	10282-104F3	14.19	2.13	3.55	0.71	0.00
skeletal muscle, adult, pool1	10023-101D5	15.47	6.48	5.64	2.40	0.84
skeletal muscle, fetal, donor1	10066-101I3	7.04	5.03	3.02	1.01	0.00
skin, adult, donor1	10074-102A2	0.00	0.00	6.79	0.00	0.00
skin, fetal, donor1	10065-101I2	8.84	5.68	5.68	2.52	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	33.02	16.01	15.01	3.00	3.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	67.45	21.12	14.50	2.52	1.58
small cell lung carcinoma cell line:DMS 144	10841-111E4	72.67	26.60	19.85	3.08	2.70
small cell lung carcinoma cell line:LK-2	10541-107H1	68.40	25.71	15.49	5.60	2.80
small cell lung carcinoma cell line:NCI-H82	10842-111E5	67.88	21.55	15.76	3.06	1.61
small cell lung carcinoma cell line:WA-hT	10562-108A4	40.97	23.10	11.11	2.40	1.31
small intestine, adult, pool1	10024-101D6	16.72	7.29	5.97	1.07	0.36
small intestine, fetal, donor1	10064-101I1	16.22	5.90	3.93	0.74	0.98
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	38.98	15.39	12.82	2.56	1.03
smooth muscle, adult, pool1	10048-101G3	15.25	4.14	3.10	1.03	0.26
somatostatinoma cell line:QGP-1	10781-110G7	47.71	5.09	4.56	1.07	0.54
spinal cord - adult, donor10196	10181-103D1	6.88	7.34	5.74	1.61	0.46
spinal cord, adult, donor10252	10159-103A6	11.04	5.91	7.49	0.79	0.79
spinal cord, adult, donor10258	10369-105F9	2.08	8.99	0.00	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	23.78	5.49	4.88	0.00	0.00
spinal cord, newborn, donor10223	10359-105E8	22.50	15.61	6.89	4.13	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	9.11	7.47	5.08	1.34	0.60
spleen, adult, pool1	10025-101D7	13.00	11.89	9.47	2.20	0.99
spleen, fetal, pool1	10044-101F8	20.02	12.32	11.36	1.43	0.95
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	15.01	13.77	15.94	1.97	2.69
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	15.00	16.52	14.62	4.18	1.71
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	11.53	19.92	18.52	4.89	1.40
squamous cell carcinoma cell line:T3M-5	10616-108G4	15.64	10.95	12.12	0.39	1.17
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	14.86	22.06	19.14	4.95	1.80
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	44.90	33.46	15.25	2.12	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	30.04	25.38	11.85	2.54	0.85
stomach, fetal, donor1	10062-101H8	21.36	8.54	9.61	0.00	2.14
submaxillary gland, adult	10202-103F4	13.10	5.70	5.70	2.28	0.57
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	14.12	10.18	5.82	1.87	1.66
substantia nigra, adult, donor10258	10371-105G2	6.72	8.28	0.00	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	16.25	10.60	10.60	2.12	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	11.69	23.16	18.57	2.98	2.75
temporal lobe, adult, pool1	10031-101E4	21.45	4.58	4.83	0.59	0.59
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	26.35	5.70	4.99	0.71	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	49.67	3.96	4.83	0.44	0.00
tenocyte, donor1	11763-123H8	17.11	8.03	5.59	0.35	1.05
tenocyte, donor2	11765-123I1	12.97	9.54	8.39	1.53	0.38
tenocyte, donor3	11768-123I4	16.31	11.86	5.56	1.11	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	41.64	28.04	23.45	4.93	2.89
teratocarcinoma cell line:NCR-G1	10798-110I6	49.17	15.11	8.02	2.00	1.70
teratocarcinoma cell line:PA-1	10807-111A6	14.10	16.58	11.00	2.32	1.39
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	17.90	27.93	24.12	4.19	3.05
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	46.89	13.24	9.45	1.13	1.13
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	11.45	18.32	10.14	3.16	0.98
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	50.48	16.29	17.59	2.61	1.63
testis, adult, pool1	10026-101D8	41.98	8.80	7.95	1.29	0.75
testis, adult, pool2	10096-102C6	64.51	13.98	10.83	1.80	0.45
thalamus - adult, donor10196	10168-103B6	9.94	2.21	2.21	0.00	0.00
thalamus, adult, donor10252	10154-103A1	16.25	9.85	10.47	2.34	2.03
thalamus, adult, donor10258, tech_rep1	10370-105G1	23.09	3.08	1.54	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	3.95	4.28	2.31	0.49	0.00
thalamus, newborn, donor10223	10366-105F6	14.96	17.83	7.48	2.88	1.15
throat, adult	10209-103G2	9.49	13.48	9.49	1.75	1.25
throat, fetal, donor1	10061-101H7	13.10	8.23	6.70	1.22	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	74.92	23.45	17.69	3.38	2.98
thymus, adult, pool1	10027-101D9	17.00	17.89	14.12	2.68	0.80
thymus, fetal, pool1	10043-101F7	15.48	23.38	22.55	2.70	3.22
thyroid carcinoma cell line:KHM-5M	10776-110G2	23.40	13.30	10.77	1.06	1.33
thyroid carcinoma cell line:TCO-1	10783-110G9	21.23	6.15	5.17	1.68	0.70
thyroid, adult, pool1	10028-101E1	27.25	10.54	8.86	1.40	0.56
thyroid, fetal, donor1	10060-101H6	12.13	9.23	7.91	1.32	0.79
tongue epidermis (fungiform papillae), donor1	10288-104F9	46.19	15.40	6.16	6.16	0.00
tongue, adult	10203-103F5	15.35	11.63	6.98	2.33	0.70
tongue, fetal, donor1	10059-101H5	18.13	6.31	4.73	0.39	0.79
tonsil, adult, pool1	10047-101G2	23.14	15.73	13.62	2.10	1.80
trachea, adult, pool1	10029-101E2	14.97	12.52	9.57	2.21	0.90
trachea, fetal, donor1	10058-101H4	28.85	8.85	6.54	2.31	1.15
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	15.23	7.79	7.79	0.71	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	19.05	32.22	23.81	3.95	1.52
transitional-cell carcinoma cell line:JMSU1	10492-107B6	37.60	17.86	12.85	2.19	1.72
tridermal teratoma cell line:HGRT	10694-109G1	26.64	13.32	19.03	5.71	3.81
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	12.02	4.66	3.56	1.19	0.42
umbilical cord, fetal, donor1	10057-101H3	8.35	2.09	4.17	0.00	0.00
uterus, adult, pool1	10100-102D1	35.49	9.38	2.73	0.17	0.00
uterus, fetal, donor1	10055-101H1	36.35	9.73	10.75	3.07	1.54
vagina, adult	10204-103F6	11.63	9.69	5.82	1.94	1.29
vein, adult	10191-103E2	14.91	8.77	7.23	1.75	0.88
xeroderma pigentosum b cell line:XPL 17	10563-108A5	11.75	10.41	4.54	1.07	0.53